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Abstract 
This research work focused on the development of a suitable analytical platform able to achieve a 
multiparametric assessment of nanoparticle (NPs) suspensions, and its integration in the 
development of bioactive nanoproducts in a safety-by-design approach. The area of application 
covered silver nanoparticles (Ag NPs), as they are highly promising in healthcare settings. In this 
work, the analytical platform designed was applied in the various steps of nanoparticles synthesis 
and application, to provide reliable information and correlate nanoparticles properties and effects. 
Nanoparticles are enabling tools for various applications. Thanks to their high surface/volume ratio, 
they present a significantly different activity with respect to that of smaller compounds. Sustainable 
development of nanotechnology, as well as its use in other relevant medical applications must avoid 
any adverse effect on humans and to the environment exposed to nanomaterials. A solid 
comprehension of mechanisms leading nanoparticles’ biological reactivity is required. However, 
even though there are extensive studies focused onto the single aspects of nanoparticles’ design 
(either toxicity mechanism, synthesis optimization or effectiveness as antimicrobials), to date that 
has not been a clear and rational protocol to assess all the needed parameters and correlate them into 
what could be defined as a “material’s performance” assessment report.  
Such a goal is particularly important when toxicity assessment of silver colloidal systems is 
addressed, given their potential in medical/healthcare applications.  
The production of auto-sanitizing products for healthcare is highly desirable given the increasing 
incidence of healthcare-associated infections (HCAIs). With the pressing need to prevent HCAIs, it 
is expected that the use of silver nanoparticles in medical devices, equipment and textiles will 
further expand. The increased usage of nanoparticle-based medical devices has raised the attention 
of the European and International regulators and occupational safety community, leading to new 
guidelines for safety assessment of nanotechnology-enabled medical devices.  
For its antiseptic properties silver is widely used as additive in antimicrobials and wound 
treatments, but its adverse effects need to be clarified. In particular, if on one hand the use of silver 
nanoparticles (Ag NPs) can provide a longer lasting effect and a lesser resistance from bacteria, the 
exposure of consumers to a nano-dimensioned substance can lead to particle specific effects, since 
there is still an ongoing debate about the mechanism by which Ag NPs exert toxicity, and its 
consequential antimicrobial effect .  For example, in addition to the commonly accepted mechanism 
of the release of cationic Ag as a primary mechanism of antibacterial action, evidences of a particle 
specific activity have also been reported. 
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My work intended to address the lack of existing platforms to obtain coherent information 
pertaining the Ag NPs samples, and to provide more than simple characterization. Ag NPs were 
characterised based on a separation step (achieved with hollow-fiber flow-field flow fractionation) 
followed by characterization through light scattering techniques and fraction collection, to assess 
together the antibacterial activity and the toxic response of human cells to different Ag NPs. The 
nature of the separation, and the simultaneous quantification of free ions, allowed for the 
recollection of separated Ag NPs that could be selectively tested for toxicity and activity. This is a 
new feature that overcomes the a priori calculation of the contributions of ions, medium, and other 
contaminants and provides a direct quantification of particle-specific effect. 
The first part of this work represents a feasibility study on the use of HF5-MALS for silver NPs 
fractionation in water and potential silver ions recovery from standard samples for further 
quantification. 
Then, the upgrade and further development 
provided a deep characterization of silver NPs 
used in the pharmaceutical field. It was possible 
to obtain fundamental information on their 
size/morphological characterization and Ion 
release quantification in various conditions such 
as dilution, preservation media, coated surface, 
with high recovery and reproducibility, in order 
to be used as potential tool in analytical platform 
for the quality control of these nanoproducts. The 
results of characterization obtained in different 
step of NPs preparation, production or 
preservation can be related to their use or development.  
To address toxicity issues and identify the purpose-specific applicability window or silver 
nanoparticles a five-step procedure was devised, able to accomplish 1. Characterisation of the 
particles in suspension to match in vitro tests, 2. Testing of the nanoparticles to quantify their 
antibacterial response (acute and in a life-cycle scenario), 3. In-vitro test to assess toxic response 
upon contact (skin model), 4. Testing of collected, purified nanoparticle to assess particle-specific 
activity, and 5. Correlation of relevant properties and nanoparticles activity (antiseptic/toxic). 
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Four different silver nanoparticles have been tested to correlate the particles antiseptic activity and 
toxicity to their physicochemical properties. These preparations were characterized in terms of size, 
shape, charge and ionic content. The separation technique used for this task is Hollow-fiber flow 
field-flow fractionation (HF5) coupled with UV (PDA) detector and a Multi angle light scattering 
(MALS). Field-flow fractionation is a soft separation technique that exploits the combination of two 
flows of carrier liquid to achieve hydrodynamic separation. The particles are separated from the 
unreacted media and the ionic fraction, collected and stored – since as opposite to ultrafiltration, 
this technique is non-destructive. This way, since both species (nanoparticles and free ions) are 
recovered, it is possible to quantify the free silver fraction and by subtraction the “nanosilver” 
fraction.  
The MALS detector output gives the gyration radius which, correlated to the hydrodynamic radius, 
determines the shape ratio of the particles. The online 3D spectrum highlights the qualitative 
differences in the particles’ coating. 
To determine the safety of the Ag NP candidates for use as medical device I individuated the most 
relevant exposure scenario according to the SCENIHR Guidelines. Their use is meant to be as 
surface coating, and can be then defined “surface contacting”, it can interact with consumers 
(workers, patients) through contact thus “facing/interacting with skin tissue”, and it is not meant for 
topical use hence the scenario is of “limited contact” (= or <24h). Therefore, the four Ag NPs were 
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tested for cytotoxicity in two relevant models: A431 (human epithelium) and HaCaT (human 
keratinocytes). Investigating the effect of Ag NPs on two human skin models is useful since they 
represent different skin layers. A431 are representative of the outer skin layer while keratinocytes, 
also part of the stratum granulosus of the skin, can simulate in vitro the first effects of penetration of 
the nanoparticles. 
The biological assays used allowed evaluating different cytotoxicity mechanisms by assessing the 
presence of viable cells (calcein assay), the damaging of cell membranes (lactate dehydrogenase 
(LDH) assay), or the cellular metabolism (resazurin assay). Moreover, the cytotoxicity results 
obtained allowed to calculate the IC50 for each preparation of Silver nanoparticles and to compare 
the values of IC50 obtained between the different assays. Using a novel bioluminescent Escherichia 
coli (E. coli) strain, the real time effects of the AgNPs on bacteria could be evaluated.  
Concentrations of PVP-type AgNPs of 40 ppm were highly effective in controlling the growth of 
bacteria.  To put this figure into context, chlorine-based disinfectants (bleach) are normally used at 
500 ppm.  
More importantly, the AgNPs remained active for more than 7 days and remained micro-biocidal on 
re-challenge with freshly inoculated bacterial.  Thus, AgNPs are highly active and, in contrast to 
standard disinfectants, they provide for long-term biocidal activity without the needs for continuous 
replenishment. Therefore one could conceptually envisage the incorporation of these particles into 
materials that are surface-exposed in the hospital environment. Thus, areas where these materials 
are in place would have a lower bacterial burden. In turn, these materials could be strategically 
deployed to areas that might have a higher probability of HAI transmission, e.g. Clostridium 
difficile patient room. 
To summarize the results in a compact view it is possible to rationalize the property-effect 
relationships between the evaluated parameters, establishing a basis to categorize the key 
parameters needed to predict nanoparticle activity. The following Figure shows how the different 
physicochemical properties (PCP) of the Ag NPs can impact toxicity on skin cells and antiseptic 
activity. 
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By exploiting this multi-step approach, based on characterization, toxicity assessment and activity 
evaluation, it is possible to extrapolate which combination of physicochemical properties is the 
most effective. This result can be expanded over the four candidates screened and represents a 
process for the selection of the required PCP set needed for a successful antiseptic medical device. 
Small particles with a negative surface charge and a higher ionic content like Ag PVP are acutely 
toxic and, even though antiseptic, have a small window of concentrations that can be exploited for 
surface treatment since the two trends go accordingly. Even bigger particles, as Ag Pristine, that 
possess the same charge and ion content parameters, display a similar behaviour. Strongly 
negatively charged particles like Ag CIT do not show remarkable effects and are not good 
candidates. Instead, the combination of a positive surface charge, a very low amount of free silver 
ions, and a size above 20nm leads to the best candidate, represented in this work by Ag HEC. In 
fact, this preparation showed a low acute toxicity, a good cellular recovery after a 24h exposure, 
and a remarkable long-term antiseptic activity. This is especially true for purified particles, where 
the decrease in bacterial viability was 80% (at 96h of exposure) even for very low concentrations of 
nanoparticles. 
Based on the results obtained, and to further test the capability of this analytical platform as an 
integrated tool for nanomaterial development, I have undertaken a more focused study of the 
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mechanisms of toxicity exerted from AgNPs. This part consisted in the development of a method to 
quickly screen the potential of antiseptic nanoparticles as surface coating agents. A work plan based 
on the selection of the most informative tests was developed: through the implementation of a 
multidisciplinary approach, nanoparticles in suspension have been characterized, purified and tested 
for toxicity, while their toxicant mechanism has been investigated through high-content screening.  
 
 
 
The materials used were Ag NPs optimised on the basis of what obtained in the first study, and in 
particular three materials were chosen: Ag PVP, Ag HEC1, positively charged, Ag HEC2, 
(modified synthesis), positively charged and with a higher amount of free ions, with their respective 
nano-fractions obtained through HF5 analysis. The unfractionated and fractionated particles have 
been screened for their toxicant mechanism (lysosomal and mitochondrial activity) in order to 
compare global and nano-specific effects. 
The obtained results indicated that HaCaT cells, fractionated Ag nanoparticles, and lysosomal 
activity after 12 and 24h of exposure were the most informative skin model, reference sample, 
toxicant mechanism and time points, respectively.  
The nanoparticles used in this study were also used to coat glass cover slides to simulate their 
application.  
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The aqueous supernatant collected was used to verify the presence of released nanoparticles: only 
Ag PVP showed to form a stable coating even at a high concentration of starting material. The 
results were confirmed via HF5 analysis. This approach proved to be effective and can provide a 
useful tool for the fast screening of nano-sized coating agents. 
The analytical platform devised demonstrated its potential during every step of Ag NPs design. 
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Introduction 
Silver Nanoparticles: applications and characterization needs 
 
Nanoparticles are interesting tools for various applications 
1
. Thanks to their high surface/volume 
ratio, they present a noticeably different activity with respect to that of smaller compounds.  
The rapid growth of nanoscience and nanotechnology has had a great influence on a number of 
industries and particularly in the pharmaceutical industry 
2
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4
 
5
. Nanotechnology is being employed 
in the pharmaceutical field for many purposes among which the improvement of drug 
solubility/bioavailability and the controlled delivery of drugs. It is also being employed to develop 
new and focused therapeutic devices. Research topics include nanobiosensors and nanodevices, 
nanoscale tools, nanoscale instrumentation, and nanomanufacturing. It is, therefore, important to 
develop a scientific approach for strategic implementation of nanotechnology tools in the 
pharmaceutical industry. Ethical, scientific and regulatory issues such as cytotoxicity, undefined 
safety issues and environmental impact of nanomaterials, determine various challenges in the 
development of pharmaceutical nanotechnology; thus the urgent need to regulate these 
nanotechnology based products and delivery devices.  
Examples of few FDA approved nanotechnology based products, which entered the market, are 
liposomes, nanoparticles, monoclonal antibody-based product, polymer-drug conjugates, polymer–
protein conjugates and some polymeric drugs 
6
. 
Some points should still be addressed in order to fully exploit the advantage of nanoparticles use 
and support its growth: the definition and characterization of model nanomaterials, the development 
of toxicity testing protocol, the measurement of the impact of environment, and the development of 
biocompatible hybrid systems. For each material, it is fundamental to assess agglomeration and size 
distribution of nanomaterials both under the conditions of toxicity testing and as expected in the 
final product, presence of impurities, potential aggregation and agglomeration in the final product, 
dosimetry for in vitro and in vivo toxicology studies, and in vitro and in vivo toxicological data on 
nanomaterial ingredients and their impurities 
7
.  
Such relevance is also justified by the fact that surface engineered metal nanoparticles find their use 
also as therapeutic agents in drug delivery applications; moreover, their dimensions match that of 
biological building blocks, from proteins to organelles, leading to question about interactions with 
living organisms 
8
 
9
. The use of nanoparticles as drug carrier may reduce the toxicity of the 
incorporated drug and the toxicity of the whole formulation is investigated. However, results of the 
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nanoparticles alone are not often described, and a discrimination between drug and nanoparticle 
toxicity cannot be made. A specific emphasis on the toxicity of the “empty” non-drug loaded 
particles is instead particularly important when slowly- or non-degradable particles (as metal 
nanoparticles) are used for drug delivery since they might show persistence and accumulation on 
the site of the drug delivery, eventually resulting in chronic inflammatory reactions. 
The development of safer by design nanomaterials, based on surface engineering could effectively 
represent an inherent safety approach, able to design out hazard at the source. Nevertheless, to 
ensure the effectiveness of such preventive measures, it is necessary to perform a deep 
characterization of physicochemical properties, affecting biological and functional properties, while 
a solid comprehension of mechanism leading nanoparticles biological reactivity is required. In 
particular, the discrimination between different hazard determining factors within and outside the 
complex biological matrix is fundamental in order to establish strategies that can mitigate the risk.  
It is of outmost importance to have access to a set of analytical tools to fully characterize 
nanomaterials, understanding to what extent –and in which way- such materials interact with living 
beings and the environment. This approach cannot be limited to an accurate description of the 
newly composed material, but needs to be equally reliable when considering the modified state of 
nanomaterials, which undergo changes in their composition, size, shape and core-shell properties 
10
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13
. 
Design and synthesis of nanoparticles (NPs) with a controlled size distribution and novel 
physicochemical features are key aspects in the development of current nanotechnology. Many 
properties of NPs are size-dependent, and the particle size distribution (PSD) thus plays a 
fundamental role in determining NPs properties 
14
. 
Although there are no standardized methodologies for NP control, FDA has produced guidance 
documents for the utilization of nanotechnology in the food and cosmetics industries as an effort 
step towards detection or characterization of nanomaterials. The NCL, which has the mission to 
assist the regulatory review of nanotechnologies for clinical applications, has an assay cascade for 
the physiochemical characterization (size distribution, molecular weight, density, surface area, 
surface charge density, purity, surface chemistry, and stability of nanomaterials including the 
particle’s; and batch-to-batch reproducibility) and most of them are tailored for specific NPs. 
Among listed analytical techniques, for size distribution there are batch-mode dynamic light 
scattering (DLS), atomic force microscopy, transmission (TEM) and scanning electron microscopy 
(SEM) and differential mobility analysis; for zeta potential measurements there are zeta potential, 
electrolytic conductivity and pH; and for chemical composition ICP-MS and RP-HPLC‒ICP-MS.  
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However, different methods for the size characterization of NPs can only give partially correlated 
size information, because the definition of “size” (e.g. geometrical, or hydrodynamic, or optical 
size) is method-dependent. Therefore, there is not a single method able to fully size-characterize 
complex NP samples, and it can be impossible to compare the results obtained by different 
methods. SEM and TEM allow direct determination of the geometric size and shape of NPs and are 
among the most used techniques to size characterize NPs. However, the observed size/morphology 
may significantly differ from the native size/morphology that the NPs display in liquid dispersion. 
Light scattering (LS) methods are also broadly used to size analyze NPs, and DLS is perhaps the 
most widespread technique for their hydrodynamic size distribution analysis 
15
. 
Recently Nanoparticle Tracking Analysis (NTA) was shown to complement DLS for the 
characterization of drug delivery nanoparticles and protein aggregates 
16
. However, DLS gives no 
information on particle shape and density distribution and, in case of samples with complex, 
multimodal particle-size distribution (PSD), the accuracy of DLS-based PSD analyses may be 
intrinsically limited. Static, multi-angle LS (MALS) gives independent information on NP root-
mean-square (rms) radius values and molar mass (Mr) if the optical properties of the particles are 
given (dn/dc or ε)17. Consequently, it may provide information on conformation and structure of the 
NPs. As in the case of DLS, MALS detection accuracy is however reduced for NPs with complex 
and multimodal PSD. Hyphenation of DLS or MALS detection with size-based separation methods 
can therefore enhance the accuracy of morphological analysis of complex NP samples. Using size 
separation methods, nearly monodisperse NP fractions can also be collected for micropreparation 
purposes, and/or for in-line or off-line characterization of features due to the chemical 
functionalization, such as analysis of the spectroscopic properties. Size-exclusion chromatography 
(SEC) has been employed to size separate complex NP samples. However, SEC selectivity is quite 
limited for very large analytes such as aggregated proteins or NPs, which can display a high 
hydrodynamic radius, and interactions with the stationary phase can alter NP morphology, retention 
time, and recovery, with consequent severe alteration of PSD analysis results. This is also true for 
packed-column, hydrodynamic chromatography (HDC).  
Such a goal is particularly important when toxicity assessment of silver colloidal systems is 
addressed, since there is still an ongoing debate about the mechanism by which AgNPs exert 
toxicity, and its consequential antimicrobial effect 
18
. Despite the common accepted mechanism for 
which the release of cationic Ag represents the primary mechanism of antibacterial action, 
evidences of a particle specific activity are also reported. Silver nanoparticles (Ag NPs) are widely 
used in pharmaceutics, medicine, and dentistry. Some examples are: treatment of ulcerative colitis 
15 
 
and acne, detection of vital structures, molecular imaging of cancer cells, coating of implants for 
joint replacement, coating of hospital textiles 
19
 
20
. 
Silver NPs are widely used as antimicrobial agents and it is known that the antibacterial activity of 
the Ag-NPs is structure (morphology) dependent 
21
. 
The antibacterial activity of silver is well known, and it is accepted that silver NPs in aqueous 
solution release silver ions, which are biologically active and actually mediate the bactericidal effect 
22
.  
Indeed silver ions are powerful antimicrobials themselves, but they are easily sequestered by 
chloride, phosphate, proteins, and other cellular components. Silver nanoparticles instead are less 
susceptible to being intercepted and display a more effective delivery mechanism
23
. The effect of 
the nanoparticles themselves is still uncertain, even though the hypothesis based on their capability 
of acting as carrier of toxicant Ag
+ 
ions -adsorbed on the surface- seems to be the most reliable 
24
. 
In both cases Ag particles properties such as size, free surface area, charge will affect the 
bioavailability of ions in terms of dissolution or transport and interaction with biological targets 
25
 
26
 
27
. 
In the biomedical field, silver (in the form of Ag NPs) is used either in pristine form or in 
combination with other materials mixed or coated over Ag NPs. As an example of application of 
hybrid system, Ag NPs with diamond-like carbon were used as coating matrices on the medicinal of 
heart valves and stents for its antimicrobial activity 
28
.  
The biological effect of the nanoparticles is largely unproven, but it can be supposed that it is due to 
their delivery of toxicant Ag+ ions adsorbed on the surface
29
 
24
. It is suggested that the antibacterial 
activity is due to the generation of silver ions in the aqueous solution binding with the proteins on 
the bacteria cell membrane and inhibiting cell respiration and reproduction 
30
. Particles size, free 
surface area, shape and charge will affect the bioavailability of ions in terms of dissolution or 
transport and interaction with biological targets 
25
  
26
 
27
. 
Toxicity refers to any deleterious effects on an organism upon exposure to silver. Obviously, if the 
practical intent is to disinfect or sterilize a specific type of organism, then toxicity may be 
interpreted as a positive outcome (e.g., antibacterial, antiviral, etc.). However, if the same material 
exerts unintended or undesired impacts to other organisms, then such toxicity may be interpreted as 
a potential hazard 
31
. An ideal antimicrobial candidate therefore needs to be selectively toxic, i.e., it 
is anti bacterial at a given concentration but non toxic to humans.  For a realistic evaluation of 
risk/benefit ratio, the comparison between human toxicity and antimicrobial effect has to be 
considered in terms of exposure times which may differ considerably 
13
 e.g. a treated inanimate 
16 
 
surface (such as a wall) is unlikely to have a long human exposure time (contact) while the 
antiseptic effect can be evaluated over a longer period.  
Concerns have been raised currently regarding the potential toxicities of Ag NPs 
32
. For example, 
the SCENIHR scientific committees highlighted the importance of considering the different forms 
of silver used in consumer and medical products, since Ag NPs undergo several transformations as 
aggregation, agglomeration, dissolution and subsequent speciation. The chemical species that are 
actually present determine the bioavailability and toxicity of silver in the environment 
33
.  
Focusing on medical devices, the “Guidance on the Determination of Potential Health Effects of 
Nanomaterials Used in Medical Devices” -where nanosilver is widely mentioned- addresses the 
specific aspects that need to be considered in the safety evaluation of nanomaterials. This guidance 
highlights the need for special considerations in relation to the safety evaluation of nanomaterials, 
in view of the possible distinct properties, interactions, and effects that may differ from 
conventional forms of the same materials 
34
. It recommends a step-wise approach where the first 
step is the chemical identification and characterisation of nanomaterials used in the production of a 
medical device. Relevant methods for nanomaterial characterization may include size separation 
and extraction and chemical analysis/detection by spectroscopic or mass spectrometric techniques
34
. 
The European NanoSafety Cluster has also come forward by suggesting a multi-step approach 
based on the implementation of the three classes of characterization techniques: imaging-based, 
light scattering-based, and separation-based. Such platform should be able to measure nanoparticle 
primary size, the size distribution in complex matrices, while providing information on different 
populations present and their surface properties 
35
. 
Overall, nanoparticles (and AgNPs in general) need to be carefully studied along the entire path of 
their synthesis, development and application.  The opportunity of using a separation step embedded 
in the characterisation procedure is able to give additional information and purified, isolated 
particles for focused studies. Such an approach is useful in every step of nanoparticles production, 
and is the aim of this dissertation. Starting from industrially synthesised Ag NPs, and ending to a 
simulation of application as a medical device, the need for an analytical platform which could be 
robust enough to face different conditions, but soft enough to avoid sample modification, has been 
explored. 
The necessity of a novel characterization approach arises for example from the synthesis steps. The 
synthesis of Ag NPs can be obtained by various chemical approaches, including chemical reduction 
using a variety of organic and inorganic reducing agents, electrochemical techniques, 
physicochemical reduction, and radiolysis. Most of these methods are still in development stage and 
17 
 
show open issues related to the stability and aggregation of NPs, control of crystal growth, 
morphology, size and size distribution. 
Parameters that are influenced by the synthesis method used include the mean NP diameter and 
size, size distribution, NP shape, stability, inclusion of ligand shells and capping agents protecting 
the NS core, chemical yield of the reaction, and the presence of impurities. Therefore, it is 
important to elucidate the effects of reaction conditions on morphology and size of NPs. 
The correspondence between particles’ structural and surface properties and their biological activity 
is however still an open question: even though particles structure can be obtained through TEM 
images it is unreasonable to take such a result as an absolute. In fact, when suspended, particles tend 
to form aggregated species with a high variability in terms of size, shape and number of 
aggregation. DLS and Zetasizer can characterize the suspended systems in terms of hydrodynamic 
radius and zeta potential, but no information on the actual shape of the particles –hence e.g. an 
estimation of the surface/volume ratio- is given. In fact, in a dynamic environment changes in the 
nanoparticle dispersions may go unnoticed because the particle diameter undergoes only a minor 
change. A DLS experiment of aged particles would typically be accepted as quality control that the 
particles did not change during storage, but this experiment would not reveal a dissolution 
phenomenon
22
. It is in fact suggested that the rate of dissolution depends not only on the chemical 
species but also on the particle size and the surface functionalization 
36
. 
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Flow field-flow fractionation as a suitable analytical technique 
 
As said, most of the NP properties are size-dependent, and particle size distribution (PSD) then 
plays a fundamental role in determining NPs properties. NPs can be prepared with different shapes 
ranging from nanospheres, nanorods, nanoplates with different in vivo activity; since size 
determines the ability of NPs to permeate cell membranes and accumulate to the target site (for 
instance, it is known that larger structures accumulate in areas of leaky vasculature typical of solid 
tumors), NPs must have a well controlled size distribution. Moreover, optical properties of NPs also 
play an important role for their use in nanomedicine. The use of different materials (semiconductor, 
metallic, functional materials) for NP preparation allows for exploiting several optical phenomena 
including semiconductor photoluminescence, optical microscopy or light-induced drug activation. 
The lack of well-assessed, robust routine methods for quality control analysis and characterization 
of NPs makes their use still limited, as highlighted by regulatory institutions such as the USA Food 
and Drug Administration (FDA) and the European Commission. Since the definition of “size” (e.g. 
geometrical, hydrodynamic, or optical radius) is method-dependent, there is not a single method 
able to fully size characterize complex NP samples, and the comparison between results obtained by 
different methods may be hard to interpret. At present, scanning and transmission electron 
microscopy (SEM, TEM) are among the most used techniques to characterize NP size and shape. 
However, due to the sample preparation steps required by these methods, the observed 
size/morphology may significantly differ from the native features that NPs display in liquid 
dispersion. Light scattering (LS) methods, in particular dynamic LS (DLS), are able to measure NP 
hydrodynamic size distribution. However, DLS accuracy may be limited when it is applied to 
highly size-dispersed analytes with complex multimodal PSD. Static, multi-angle LS (MALS) gives 
uncorrelated information on the NP relative molar mass (Mr) and root-mean-square (rms) radius 
values, related to conformation, core-shell structure and surface properties of the NPs 
17
. 
As in the case of DLS, MALS accuracy is reduced for NPs with complex and multimodal PSD, 
particularly in the presence of large NP aggregates. Hyphenation of DLS or MALS detection with 
size-based separation methods represents a multidimensional platform able to enhance the accuracy 
of size analysis of complex samples. Moreover, separation methods are necessary to isolate the 
newly synthesized NPs from the reagents in solution making coupled detection methods able to 
accurately characterize the properties of isolated NPs.  
Size-exclusion chromatography (SEC) is widely applied to size-separate complex NP samples. 
However, SEC selectivity decreases when applied to very high Mr analytes such as NPs, and 
interactions with the stationary phase can affect NP morphology, and determine size-dependent loss 
19 
 
in recovery, with consequent severe alteration in the results of PSD analysis. Similar limitations 
apply to packed-column, hydrodynamic chromatography (HDC). 
Flow field flow fractionation (F4) is a flow-assisted technique ideally suited to size-separate 
dispersed analytes over a broad size range 
37
. In F4 retention is inversely proportional to the 
hydrodynamic diffusion coefficient of the analyte and, consequently, to its hydrodynamic size. Over 
more than 30 years, F4 has evolved from a research-oriented technique to a well-assessed 
methodology and it has been recently approved by FDA as a technique that complements SEC in 
the validation of protein products 
38
. This is because, unlike SEC, F4 selectivity is particularly high 
in the high-Mr and nanometer-size range, and because the absence of a stationary phase prevents 
any mechanical or shear stress on the analyte. This makes F4 particularly suited to the analysis of 
delicate, nanosized samples 
39
 
40
. F4 is increasingly used as a mature separation method to size sort 
and characterize NPs by MALS and fluorescence 
41
 
42
 
43
 also in the biomedical field 
39
 
44
.  
F4 was also hyphenated with DLS and ICP-MS for the speciation and quantification of silver NPs 
also in biological medium 
45
 
46
 
47
 
48
 
49
 
50
. 
In the analytical platform proposed for this thesis, the miniaturized variant of F4, hollow-fiber flow 
field-flow fractionation (HF5) was used. In HF5 the separation channel consists in a tubular 
membrane with porous walls made of polymeric or ceramic materials. Due to the fiber porosity, the 
flow entering the channel is split into two components: a radial flow (hence cross-flow) which is the 
driving force of separation perpendicular to a migration flow (axial/longitudinal flow). Down-
scaling of the separation channel shows important features for its application in the pharmaceutical 
field convenient because the lower dilution allows to increase the limit of detection of the speciating 
analytes, avoid reconcentration steps, and obtain collectable fractions of “washed” nanoparticles 
which can be used for selective activity tests. In addition the cross flow density is higher than in 
AF4 leading to an increase in separation efficiency and disposable usage of the separating channel 
eliminates sample carry-over or sample contamination issues 
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55
. The only limitation 
could be the reduced amount of sample that can be injected, which hinders the use of HF5 in 
preparative scale. 
Despite the broad applications of HF5 systems for protein and proteins aggregate characterization, 
only few papers show potential use of HF5 for NP characterization. Some of them are related to 
metal NP speciation and quantification 
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60
.  
When online coupled to uncorrelated detection method including MALS, DLS, absorbance and 
luminescence spectrophotometry, HF5 thus allows performing multidimensional characterization of 
NPs, providing the following results: 
(1) accurate, high-resolution NP size distribution analysis (in terms of hydrodynamic or rms radius); 
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(2) investigation of NP aggregation in native conditions, which is always a critical aspect in any NP 
application; 
(3) separation of the unbound constituents of the functional NPs, which can be a key step for the 
optimization of NP synthesis; 
(4) determination of the optical features of the NPs, separated from other dispersion components 
including free chromophores, and of the correlation of spectroscopic properties with NP size.  
HF5 shows unique, intrinsic features such as low channel volume with reduced sample dilution; low 
flowrate conditions allowing direct connections with other analytical instrumentations such as MS; 
possible disposable usage, which eliminates the risk of run-to-run sample carry-over. At present, 
HF5 is increasingly applied to proteins analysis, but few applications on NPs were developed so far. 
On-line coupling of AF4/(HF5) with MALS appears to be an ideal, hyphenated methodology for the 
simultaneous size separation and characterization of complex NP samples because they provide 
independent size information. NPs are separated from the (relatively) low-Mr sample components 
used as functionalizing reagents; and additional information on the “bound” and “unbound” 
components is obtained from on-line spectroscopic characterization. Moreover, the rh values 
determined by AF4/(HF5) can be correlated to the rg values determined by MALS and information 
on particle shape and morphology can be obtained since rh/rg values depend on particle shape. 
The first part of this work represents a feasibility study on the use of HF5-MALS for silver NPs 
fractionation in water and potential silver ions recovery from standard samples for further 
quantification 
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.  
Then, the upgrade and further development provided a deep characterization of silver NPs used in 
the pharmaceutical field. It was possible to obtain fundamental information on their 
size/morphological characterization and Ion release quantification in various conditions such as 
dilution, preservation media, coated surface, with high recovery and reproducibility, in order to be 
used as potential tool in analytical platform for the quality control of these nanoproducts. The 
results of characterization obtained in different step of NPs preparation, production or preservation 
can be related to their use or development.  
To address toxicity issues and identify the purpose-specific applicability window or silver 
nanoparticles it was devised a five-step approach based first on separation (through flow field-flow 
fractionation, FlFFF) and characterization of particles, obtaining information about the dimension, 
the shape and the effective coating of particles, and quantifying the initial free ion presence. These 
properties have been put in relation with the toxic and antiseptic effect on particles to create a 
correlation chart to be used as predictive/selection tLastly, based on the obtained results, a more 
focused study of the mechanisms of toxicity exerted from AgNPs was undertaken. This part 
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consisted in the development of a method to quickly screen the potential of antiseptic nanoparticles 
as surface coating agents. A work plan based on the selection of the most informative tests was 
developed: through the implementation of a multidisciplinary approach, nanoparticles in suspension 
have been characterized, purified and tested for toxicity, while their toxicant mechanism has been 
investigated through high-content screening. This approach proved to be effective and able to 
distinguish amongst candidates, providing a useful tool for the fast screening of nano-sized coating 
agents; the analytical platform devised demonstrated its potential during every step of Ag NPs 
design. 
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Chapter 1 – Hollow-fiber flow field-flow 
fractionation and its hyphenation 
 
1.a Hollow-fiber Flow Field-flow fractionation 
 
Field-flow fractionation (FFF), first developed by C. Giddings, is a family of separation techniques 
related but not ascribable to liquid chromatography. Unlike chromatography,
 
it applies to the 
separation of complex samples in a mobile phase (of any composition) due to a different size-
dependent migration of macromolecular and supramolecular analytes inside a channel (which is the 
equivalent of the chromatographic column). The lack of a stationary phase and related interactions 
lead the separation method to be mild and particularly indicated for delicate samples as non-
covalent aggregates. 
FFF involves the application of an external field to a solution: its constituents migrate under this 
field creating exponential concentration distributions after an equilibration step called relaxation. If 
the solution is then subjected to a laminar flow perpendicular to the external field, a parabolic 
velocity profile will develop; a thick distribution at a certain position of the flow profile has its own 
rate and is eluted at a different retention time than other distributions, providing separation. 
 
Fig 1.1. Differential migration of two different particles driven by the applied field into two 
different locations in the parabolic flow profile. 
 
FFF then needs an external field to be performed; different fields determine a different area of 
application, being effectiveness of the separation linked to two main factors.  
The first one is the need of a field that is sufficiently strong to cause the localization of analytes 
across the parabolic flow profile; second, the field is also required to be selective to guarantee an 
effective separation of different analytes through a different elevation from the channel wall. 
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It also has to be mentioned the necessity of easy implementation of the field-generating device, to 
build inexpensive and practical instruments. 
There are various choices of fields, the most used of which are Sedimentation and Flow 
(hydrodynamic) fields. The table below shows the different fields used (bold) and under study, 
listed according to their actual use. 
This order is in continuous change, due to progressive development of the various techniques. For 
example, SdFFF was the most used method until the first years of 1990s. 
 
 
Table 1.1. Practical (in bold) and Hypothetical FFF Fields, and the Corresponding Techniques 
 
As shown in Table 1, the most applied field is a crossflow, that is a stream of mobile phase 
perpendicular to the axial flowstream carrying the sample: the technique is then named Flow field-
flow fractionation (FlFFF)
61
. Being a flow the most universal field, the applicability of FlFFF 
covers 15 orders of magnitude in molecular weight and it is then possible to analyze a broad range 
of macromolecular and particulate samples from nanometric to micrometric scale 
51
. 
.
Mechanical and shear stress are avoided thanks to the lack of stationary phase in the FlFFF 
channel. Therefore, this technique is particularly suited for delicate samples like macromolecules 
(proteins and non-covalent protein aggregates) with reduced risk of sample entanglement or 
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adsorption. Moreover, in FlFFF selectivity is higher than in size-exclusion chromatography (SEC) 
for high-Mr analytes, and it remains constant with increasing Mr.   
Few FlFFF subtechniques are currently available: Symmetrical FlFFF, Asymmetrical FlFFF and 
Hollow-Fiber FlFFF (HF5). 
Commercial FlFFF channels are made up of two machined blocks that clamp together a spacer from 
which the channel shape is cut out. At least one frit panel is inserted in one (asymmetrical FlFFF) or 
both (symmetrical FlFFF) blocks to guarantee the required cross-flow.  
An ultrafiltration (UF) membrane with low MW pore cut-off is usually placed on the frit where the 
sample accumulates under the action of the crossflow.  
To delve into the mechanism of FlFFF, let’s consider the forces involved in separation. In FlFFF, 
two flow streams are superimposed. The longitudinal flow drives sample components along the 
channel and the cross-flow pushes sample components toward the accumulation wall. The driving 
force in FlFFF is the viscous force exerted on the analyte by the cross-flow stream. 
 
D
UkT
dUUfF  3       Eq. 1.1 
 
where  
D is expressed by the Stokes‐Einstein relation 
f
kT
D       
d  is the hydrodynamic diameter of the analyte,  
η the mobile phase viscosity 
U  is the cross‐flow velocity 
It is possible to correlate d with retention time: to do so, we need to focus on the relations between 
channel width w and l, the characteristic elevation of the analyte cloud from the accumulation wall. 
Separation occurs between analytes with different l. 
When w>>l, that is to say the separation is efficient, tr/t0 is expressed as  
 
R =
tr
t0
=
w
6l
=
|F|w
6kT
          
           Eq. 1.2 
Where R is the retention ratio. Being R dependent from |F|, it is explained its dependence from d as 
well. 
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Operational modes 
 
According to particle size-weight and imposed fields, different trends of separation are developed. 
Different kinds or sizes of particles are subject to different forces and thus have different 
equilibrium positions or distributions 
62
. More specifically, different kinds of opposing forces or 
effects lead to different mathematical forms of the equilibrium distribution of the sample particles 
and thus to what is known as different operating modes. When the opposing effect is dominated by 
diffusion, we have the normal operating mode of FFF. The term "normal" arises from the fact that 
this was the only operating mode utilized in field-flow fractionation until the advent of steric FFF, a 
second operating mode, in the late 1970s. 
For nanosized particles and macromolecules, in contrast with size-exclusion chromatography, small 
particles are the first to elute. Thus they are analyzed in Normal mode.  
Steric FFF is generally applied to particles of larger diameter (usually >1 µm) than normal FFF. For 
these larger particles, diffusion is ordinarily negligible in opposing the primary driving force. Thus 
these large particles are driven by the primary force directly to the accumulation wall. 
Their motion is stopped by essentially "bumping" into the wall, and thus they reach a state of 
equilibrium in close proximity to the wall. Particles of large size protrude further into the channel 
than those of small size and are caught up in streamlines of higher velocity. Therefore the large 
particles are displaced more rapidly by flow and are eluted earlier than the small particles. 
Consequently the elution order is inverted relative to that of normal FFF. 
Based on the above steric mechanism, the effective particle elevation (essentially the center of 
gravity elevation) above the accumulation wall is approximately equal to the particle radius a (even 
if the particles don’t really stick to the accumulation wall). 
Another operating mode of FFF is the hyperlayer mode, in which different particle populations are 
forced into narrow bands (called hyperlayers) located at different elevations above the accumulation 
wall. A subclass of hyperlayer FFF is lift hyperlayer FFF, in which hydrodynamic lift forces drive 
particles away from the wall and into their respective equilibrium hyperlayers. Lift hyperlayer and 
steric FFF form a continuum, with lift hyperlayer FFF applicable when the effects of hydrodynamic 
lift forces dominate pure steric effects. Arbitrarily, the steric mode is considered applicable when γ, 
the dimensionless steric correction factor  which accounts for hydrodynamic effects, is <2 (For 
steric FFF, γ ≈ 1), and the lift hyperlayer mode when γ ≥ 2. The lift hyperlayer mode appears to 
work effectively only when the primary driving force F is weakly dependent on diameter d. 
Specifically, F should increase with less than a third-power dependence on the diameter of the 
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particle d. Thus, a cross flow force, with a first-power dependence on F on d, yields excellent 
results. 
 
 
Fig.1.2 Separation mechanism in the (a) normal, (b) steric, and (c) hyperlayer modes of FFF. 
 
Symmetrical Flow FFF- SF4 
 
A FlFFF channel is made up of two machined blocks with inset frit panels that clamp togheter a 
spacer and a membrane. The blocks are usually made of Plexiglas, suitable for separations in 
aqueous media. Being the field symmetric, the channel needs both of the walls to be permeable, and 
this leads to the presence of two frits. The accumulation wall is also provided with a UF membrane, 
which is always necessary when analyzing nanosized particles and macromolecules. Moreover, it is 
fundamental to choose wisely the best membrane material to minimize analyte/membrane 
interaction, and the right cut-off.  
A standard, symmetrical FlFFF system is composed of two separate pumps that are employed to 
generate the crossflow and the longitudinal flow streams. As for other FFF techniques, the most 
common detector is the UV/vis detector for HPLC, although the use of multi‐angle laser scattering 
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(MALS) detectors is rapidly increasing, and complete FlFFF‐MALS systems are commercially 
available. 
 
Asymmetrical Flow FFF- AF4 
 
Nowadays, AF4 is the most successful variant of FlFFF. The most important difference between 
asymmetrical and symmetrical FlFFF lies in the channel, which has only one permeable wall 
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, 
as shown in Fig. 1.2. The AF4 channel design allows us to employ a special sample injection 
technique, referred to as sample focusing, which is able to reduce the analyte band broadening after 
the injection to increase resolution in analysis times shorter than with symmetrical FFF 
66
. 
Another advantage of the AF4 channel is that the sample is less diluted after elution, because the 
crossflow stream originates within the channel itself and it is not independently generated by a 
second pump as in the symmetrical channel. Since the crossflow stream is driven by the pressure 
differential across the membrane/frit assembly, the cross-flow rate through the membrane 
corresponds to the loss of axial flow that occurs in the transport of the mobile phase down the 
channel length. This leads to a continuous decrease in the axial stream velocity as it approaches the 
channel outlet. 
 
Fig. 1.3 Exploded view of an AF4 channel 
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Hollow-fiber Flow Field-flow Fractionation 
 
Both in the case of SF4 and AF4, because of possible interaction between the sample components 
and the UF membrane or the frits that constitute the channel walls, possible run-to-run sample 
carry-over due to incomplete sample recovery can occur in FlFFF. Moreover, the typical FlFFF 
channel volumes are in the order of 1 mL. This leads to a relatively high sample dilution at the 
FlFFF outlet, even if a partial improvement has been introduced with AF4. These aspects can affect 
reproducibility, sensitivity, and accuracy, particularly if further characterization of the fractionated 
analytes has to be performed by coupling orthogonal analytical methods to FlFFF. In the case of 
biological samples, moreover, contamination of the fractionated analytes can also occur, which may 
affect their viability or functionality. These issues have been faced over the last years since tubular, 
hollow-fiber (HF) filtration membranes, made of polymers or ceramics, have been effectively 
exploited as potentially disposable, micro-volume channels for FlFFF. 
 
 
Theory of HF5 
 
In a typical HF5 arrangement, a hollow-fiber (HF) is connected to a pump that generates inside the 
HF channel a flowrate Fin of a liquid flow in the longitudinal direction. A pressure drop is also 
generated between the inner and outer wall of the HF, either by a second pump that aspirates the 
liquid across the HF, or by the application/generation of a backpressure at the HF longitudinal 
outlet. Due to the pressure difference, also a radial flow Frad is generated through the HF. (Fig. 1.3). 
 
 
Fig. 1.4 HF5 and its flow dynamics 
 
Consequently, the longitudinal flowrate decreases along the HF from the initial value Fin to a lower, 
outlet value Fout, where: 
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radinout FFF          Eq. 1.3 
 
Radial flowrate next to the fiber walls ur can be written as: 
 
)exp()0,(),( zRuzRu rr         Eq. 1.4 
 
where 
:R  inner radius of the fiber 
:z  axial coordinate 
:  constant value which includes viscosity and fiber permeability  
 
Eq. 4 clearly shows how ur decreases along the fiber; by controlling the pressure values, ur results 
approximately constant (difference between ur in and ur out is less than 2%). We can then assume 
ur as uniform. The mean rate of axial flow uz decreases through the fiber because of the flow loss 
from the fiber walls,  
Assuming also a laminar flow profile along the HF
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, and a parabolic profile, axial velocity is  
 
)1)(,0(),( 2xzuzru zz         Eq. 1.5 
 
where 
r : radial coordinate 
R
r
x 
 
 
Integrating equation 5 the transport time of an unretained species in the HF, i.e. the void time t0, can 
be calculated as 







out
in
rad F
F
F
V
t ln
0
0
        Eq. 1.6 
 
where 
:0V  channel void volume ( LRV 20  , being L  the fiber length) 
Fin, Frad, Fout are expressed in volumetric terms (mL/min). 
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Operational modes 
 
Normal mode 
As said in the general FFF section, this mode is typical for sub-micrometric particles; when those 
particles are pushed towards the accumulation wall (i.e. the fiber itself, being the device tubular) 
their concentration in proximity of the wall increases and, once balanced with diffusion force, 
creates an exponential distribution. (Fig. 1.5) 
 
 
Fig. 1.5 equilibrium distribution of particle concentration. 
 
Distribution thickness is inversely proportional to the force exerted by the field to the particles and 
this force is in general smaller for small particles: smaller particles, then, will migrate faster than 
bigger ones. 
 
 
Fig. 1.6 differential migration of different particles. 
 
If analytes are introduced into the fiber, they are subjected to a relaxation/focusing process to reach 
a stationary concentration profile.  
When the equilibrium is set, the concentration profile along the radial coordinate is 
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Where 
:  integration constant 
:Pe Peclet number:  
 
   DRzRuPe r /),(            Eq. 1.8 
 
By combining Eq.1.5 and Eq.1.7 and assuming  the concentration profile to be Gaussian-like along 
the axial coordinate, it is possible to calculate the retention time; to simplify the espression we 
consider the crossflow rate to be constant. When 50Pe : 
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Where Rf is the inner radius of the fiber. 
It is now necessary to delve more into what happens into the fiber: the real position from which the 
separation starts is L0, that is to say the focusing point, and this leads to a correction of Eq.1.9 in 
Eq.1.10 
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From Eq.1.10 and Stokes-Einstein equation for the diffusion coefficient D it comes the relation 
between retention time t and hydrodynamic diameter d 
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Both Eq.1.10 and Eq.1.11 show a strong dependence of retention time on the fiber inner radius, that 
has to be strictly controlled to assure reproducibility. 
Doshi et al. have, then, expressed band broadening related to variance 
2 : 
 r
rad
t
F
DLR
2
22
2 16         Eq.1.12 
 
To obtain the equation for the number of theorical plates (N) from Eq.1.12 it is necessary to 
substitute Frad with its expression in terms of ur 
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         Eq.1.13 
Efficiency in separation is increased with cross flow rate or reducing Fin to increase the retention 
time. However, tr cannot be increased too much because overloading occurs 
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. 
The maximum value for N then is 
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where 
:c  the highest concentration (without overloading) 
:LoDc  the lowest concentration detectable 
 
Steric-Hyperlayer mode 
 
Steric mode concerns micron-sized particles, the diffusion coefficient of which is negligible 
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.  
 
Fig.1.7 Steric elution mode 
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Without considering diffusion force, the particles will adhere to the accumulation wall to form a 
thin layer. The distance between the centre of mass of the particles and the wall will then be the 
radius (of their equivalent sphere): bigger particles will penetrate more into the flow profile 
reaching a higher migration rate. Elution order is in fact opposite to that in normal mode. 
On the other hand, if this distance in greater than particles’ radius, the separation mode is called 
hyperlayer.  
Hyperlayer mode consists in the formation of thin layers of analytes lifted from the accumulation 
wall. Each layer will have a migration rate directly proportional to their distance from the 
accumulation wall, which is in relationship with their radius. 
 
 
 
 
 
Fig.1.8 Hyperlayer elution mode 
 
Bigger particles will be eluted faster because of higher lifting forces. Elution order, as said, is then 
the same of that of steric mode. 
Retention time can be expressed as 
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where  
:  steric correction factor  which accounts for hydrodynamic effects 
Once a calibration with standard particles of known size is performed, it is possible to obtain the 
relation between tr and the particle size 
dStt drr logloglog 1         Eq.1.16 
where 
:dS  selectivity 
:1rt  retention time for unitary-radius particles  
The principal differences between normal and hyperlayer modes are summarized in Table 1.2. 
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 Normal mode Hyperlayer mode 
Analytes’ size 1 – 500 μm 0.60 – 10 μm 
Opposing forces diffusion lift 
Retention time 

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d
Rt
t
f
r
2
0
  
Flow rate inF  0.1 – 0.2 mL/min 

rad
out
F
F
 0.1 – 14 
inF  3 - 4 mL/min 

rad
out
F
F
 4.7 - 14 
Theorical plates 45 – 180  216 – 720  
Table 1.2. 
 
Separation system 
 
In this paragraph are shown system the configurations for each operational step; the whole system is 
here described. 
 
Fig. 1.9 Flow scheme 
The main pump is connected to two 6-way valves, V0 and V6. V0 is the injection valve, and 
controls the flow to pass through the autosampler or bypass it, whereas V6 is the focus valve, which 
manages the switch from focus/injection/relaxation modes to elution. 
Autosampler 
Detector 
V6 
V0 Waste 
Pump 
in 
out 
crossflow 
1 
2 
3 4 
5 
6 
4 
5 
6 1 
2 
3 
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In fact, a typical HF5 separation method involves two steps: 
- Sample focusing/injection  
- Sample elution 
The first step, called focusing, consists in the sample injection into the fiber with a longitudinal 
mobile phase flow, contrasted by a second and opposite flow. In the focusing point, flow rate is 
equal to zero and the sample accumulates in a thin distribution. The focus point position depends on 
the flow ratio value. 
At the same time, a third transversal flow is generated, which creates hydrodynamic field that 
causes relaxation.   
 
Fig. 1.10 Focusing/relaxation 
 
Hence, flow values are modified to switch to elution mode: from the main pump a single flow 
enters the fiber and is then splitted in two parts: one, the crossflow, generates the  hydrodynamic 
field. The second flow carries the analytes towards the fiber outlet providing separation.  
 
Focusing 
The scheme below represents flow settings in focusing mode: 
 
IN OUT 
Focus point 
Detector 
V
6 
V0 
Autosampler 
Waste 
Pump 
crossflow 
2 
3 4 
5 
4 
5 
6 1 
2 
3 
1 6 
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Fig. 1.11 Focusing mode 
 
From the pump the generated flow is splitted in three parts; the detector flow (Vc) passes through 
V0, determining whether focusing or focusing injection is performed. This is obtained by 
exclusion/inclusion of the autosampler from the flow path. 
The Focus flow, (Vx), enters the fiber from outlet and goes to waste passing through across the fiber. 
After sample injection and relaxation, the system is set in elution mode. 
 
 
Elution mode 
 
 
Fig. 1.12 Elution mode 
 
A single flow is generated from the pump and piped to V0; this allows to choose either elution or 
elution-injection  mode.  
Generally, the chosen methods simply foresee an elution step followed by an elution-injection one 
(to clean the autosampler and the whole system as well). During the elution, the flow itself 
generates the radial field which can be constant or can set as a gradient. 
After separation, the analytes and mobile phase reach V6 and then the detector(s). Afterwards, an 
elution-inject step is required to clean the system; usually, no field is applied. Thus, it is called field 
release step. 
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1.b Detection 
 
Every separation technique needs a system to allow sample detection but also further 
characterization. The most common detection systems used in HF5 are similar to those used for 
liquid chromatography; detection can be 
- online, when the detector is directly connected to the separation system 
- offline, when detection occurs after separation and fraction collection 
The choice between different detectors relies on many factors, as sample composition, needed 
sensitivity  and information required from the analyses. 
Sample volume is not relevant, because the separative step itself shows limitation due to intrinsic 
overload effects that are typical of FFF 
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. Being the detector response generally proportional to 
sample concentration, it is common to integrate more than one detector to obtain as much 
information as possible. 
 
Light scattering 
Scattering is an optical phenomenon in which part of the incident radiation is deviated into different 
directions when it reaches discontinuity in the propagation medium. 
Models of light scattering can be divided into three domains based on a dimensionless size 
parameter, α , which is defined as α = πDp/λ , where πDp is the circumference of a particle and λ is 
the wavelength of incident radiation. Based on the value of α, these domains are: 
α <  1: Rayleigh scattering (small particle compared to wavelength of light) 
α ≈ 1: Mie scattering (particle about the same size as wavelength of light) 
α > 1: Geometric scattering/diffraction (particle much larger than wavelength of light) 
Light scattering (LS) is a non‐distructive technique for characterizing macromolecules and a broad 
range of particles in dispersion.  
Moreover, it does not require external calibration standards and then can be considered as an 
absolute technique. However, in case of samples with complex, multimodal size distribution, 
accuracy of light scattering may be also limited. 
Hyphenation of light scattering techniques with size‐based separation methods such as size‐
exclusion chromatography (SEC) or FlFFF can then improve size analysis of complex samples. 
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This is because size‐separation reduces sample complexity prior to size analysis, and this allows to 
the application of the sizing methods to narrowly distributed fractions of the samples. 
 
Dynamic light scattering 
 
Dynamic light scattering (DLS), also called photon correlation spectroscopy (PCS) or quasi‐elastic 
light scattering (QELS), is a widespread technique for particle size-dimension analysis of 
nanoparticles 
75
 . This technique is based on the fluctuations in the scattering intensity of 
nanoparticles in the dispersing medium, and it measures the Stokes diffusion coefficient (D), which 
depends on the NP hydrodynamic radius (rh). 
When coupled with FlFFF techniques, DLS can be thought as an independent tool to obtain the 
hydrodynamic size of the analytes and compare it to the one provided by the FlFFF analysis. 
 
Multi-angle light scattering 
 
Multi-angle light scattering (MALS) is an incredibly useful tool for size-shape characterization of 
nanoparticles. MALS instruments have up to 18 detectors and measures the angular dependence of 
the scattered light intensity. MALS detection allows measuring the molecular weight without 
referring to calibration if sample concentration and the specific refractive index increment (dn/dc) 
are measured or known
17
. 
In a typical experiment, the MALS detector and a concentration detector are online coupled 
downstream the separation technique. The concentration detector is usually a UV/Vis detector or a 
Differential Refractive Index (DRI) detector. MALS detection gives information on the nanoparticle 
root-mean-square (rms) radius (commonly referred as radius of gyration, rg), that is the mass-
averaged distance of each mass element in the particle or macromolecule from its center of gravity. 
The dependence of the radius on molecular weight yields information on the molecular 
conformation of the species in dispersion
76
. 
MALS detection is applicable in a size range from 1 nm to over 1 μm, but its sensitivity decreases 
with decreasing particle size.  
When a monochromatic radiation (e.g. from a laser source) interacts with a particle, light is 
scattered in all directions. 
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Fig. 1.13 Light Scattering 
 
This phenomenon is generated by the interactions between the electric field of the radiation and the 
oscillating dipole moment of the scattering element (SE), which adsorbs radiation and emits it in 
every direction with variable intensity. This intensity depends on dipole dimensions and thus on SE 
dimensions as well. 
Polarizability is directly linked with refractive index n, and then scattered light intensity may be 
expressed as 
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Scattered light is also proportional to macromolecule concentration: 
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When a system is composed by different SEs with same mass and scattering properties, two 
possibilities arise.  
If the SEs are independent one from the other, then their emitted radiation will be independent as 
well and the global scattering intensity will result as the summation of the single values  
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This is true for SEs with incoherent brownian motion. 
On the other hand, when the SEs are related and their scattered radiation have a defined phase, 
scattered light is coherent and global intensity is 
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This is true for SEs which are part of the same particle. 
By combining Eq. 1.19 and 1.20, Eq.1.21 and 1.22 are obtained: 
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Diffuse light intensity doubles in value when SEs are physically bound together: this leads to the 
conclusion that the light scattered by a molecule depends on its molar mass 
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Scattering and molar mass 
 
When α >> 1 the SE can be considered pointlike. For those particles, scattered light intensity is 
independent from the observation angle θ, and the scattering is called isotropic. 
 
Fig. 1.14 Isotropic Scattering  
 
When, on the other hand, scattering of bigger particles is considered, it is possible to suppose the 
particle to be composed of several independent SEs according to Rayleigh-Gans-Debye theory. 
Then, if the distance between the SEs is similar to λ, different phase interaction will occur at 
different angles. 
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Fig. 1.15 Diffused light at different angles 
 
Constructive and distructive interference will arise, leading to a θ-dependent scattering profile 
which is maximum when θ=0. 
Mathematically, the relationship between θ and Is is expressed by the attenuation factor P(θ):
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P(θ), moreover, includes λ (incident radiation’s wavelength), θ and particles’ size: 
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Where 
gr  is the gyration radius, which is the root mean square radius:  
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Fig. 1.16 Root mean square radius 
Center of 
mass 
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Eq. 1.26 shows that increasing rg the angular dependency of Is increases as well. 
Registering Is at different angles it is then possible to obtain informations about the particles 
dimension itself. Those measurements are effectuated using a MALS detector (Multi-Angle Laser 
Scattering), which is a system composed of several detectors, each one at a fixed reading angle. 
 
 
Fig.1.17 Laser Scattering Detectors 
 
Data analysis 
 
From the Rayleigh-Gans-Debye theory one may obtain the following equation 
17
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In which k* is expressed by 
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Where 
- 0n  is the solvent refractive index. 
- AN  is the Avogadro constant. 
- 0  is the wavelength of the incident radiation in vacuum 
- 
dc
dn
 is the refractive index variation with concentration 
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-  R  (Rayleigh ratio) is the ratio between diffused and incident light intensities  
- c   is the particle concentration (g/mL) 
- M  molar mass 
-  P  attenuation factor 
- 2A  is an hydrodynamic term which considers solvent-solute interactions.  
 
From Eq.1.27 one can obtain a linear espression: 
when θ=0°, P(θ)=1 (intramolecular ineractions are negligible) and the equation can be simplified in: 
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By plotting 
 0
*
R
ck
 and c it is possible to calculate A2 as the slope of the resulting linear function 
and molar mass from the y-intercept. 
At the same time, when 0c  2A2c is negligible and the equation becomes 
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Expliciting the expression for P(θ), Eq.1.30 then becomes: 
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By plotting 
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 it is possible from the linear regression to obtain the rms radius 
(slope) and the molar mass (y-intercept).  
However, it is possible to experimentally measure the scattered light intensity neither aat θ=0°, 
because of the presence of transmitted light, nor at c=0, because light intensity depends on particle 
concentration. 
Hence, the data have to be extrapolated from the measures of the intensities of the scattered light at 
different angles and for different particle concentrations by plotting the Zimm diagram. 
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Fig. 1.18 Zimm plot; dotted lines are extrapolaedi for θ=0°(blue) and c→0(red) 
 
This leads to the extrapolation for θ=0° and c=0; thus, the molar mass, A2 and the rms radius can be 
calculated. 
 
Molecular conformation 
When analyses of complex samples are required, it is common to hyphenate a separative technique 
with MALS. Thus, each fraction obtained trough separation can be individually characterized. In 
this case, by plotting grlog  vs Mlog  it is possible to evaluate molecular conformation, which 
depends on the slope of the linear regression. 
 
Fig.1.19 grlog  vs Mlog  
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The commercial softwares used to elaborate data offers different algorithms by which one can 
estimate the molar mass values. Each algorithm corresponds to a different mode of solving Eq.1.27: 
 
- Debye fitting: it builds a plot  vs , and it calculates a polynomial regression at 
a chosen order; it has good results for a wide range of MW.  
- Zimm fitting: it builds a plot  vs , and it calculates a polynomial regression at 
a chosen order; it is the most common fitting algorithm. 
- Berry fitting: it builds a plot  vs , and it calculates a polynomial regression 
at a chosen order; it is the most indicated for the determination of high molar mass values.  
- Random coil fitting: it sses a theorical form for . It is used for random coil 
conformations. 
 
 
UV Spectrophotometers and DAD 
 
The most common detector used in FFF systems is the UV/Vis spectrophotometer because of its 
simplicity, availability and low cost.  
UV/Vis spectrophotometers have been generally designed for use as absorption detectors in 
chromatographic systems thanks to their very low internal volumes, which minimizes band 
broadening. The simplest of these detectors operate at a single wavelength, whereas more complex 
instruments allow the detection wavelength to be varied to match the spectral properties of the 
analyte.  
The detection wavelength is generally chosen to maximize the sensitivity to the analyte while 
avoiding interferences, such as absorption by the carrier liquid. The ability to obtain the entire 
UV/vis spectra of eluting samples is provided by the photodiode array detector. UV/vis spectra are 
useful when the chemical composition of the eluting sample varies during the separation or are 
useful to verify that there is no such variation.  
Spectra can also detect a change in some physical property of the sample 
77
. 
For dissolved samples that are homogeneous in chemical composition, there is direct dependence of 
absorption from sample concentration.  
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Fig 1.20. UV detector exploded view. 
 
However, with particulate material, one may need to correct for the effect of particle size on the 
detector signal  
78
.  
In fact, these instruments are not designed for use with particulate samples, in which the signal is a 
combination of light scattering and absorption. As a consequence, the quantification of separated 
particles is not straightforward and the UV signal is actually a turbidimetric measure
79
.  
Thus, the sensitivity of such detectors to the light scattered in the forward direction may result in an 
underestimation of the fraction of the largest particles in a sample, particularly when the particle 
size is similar to the wavelength of the incident beam.  
 
Atomic absorption spectroscopy (AAS) 
 
Atomic absorption spectroscopy (AAS) methods are based on the measurement of the absorption of 
a monochromatic radiation by an element in the atomic form, which goes from the fundamental to 
the excited state. 
There are two available set ups for analysis: one uses a flame as an atomisation source (flame AAS, 
FAAS), while the other employs a grapite furnace (graphite furnace AAS, GFAAS) 
The source consists in a hollow cathode lamp made of the same element that will be analysed.  
The sample is nebulized and sprayed in the pre-miscelation chamber, from where it is brought to the 
atomization stage; the radiation is absorbed selectively by the analyte and is collected by a 
photomultiplier. The analyte concentration is extrapolated via calibration with standards, according 
to the Lambert-Beer law. The scheme of a FAAS instrumentation is reported in Figure 1.21. 
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Fig 1.21: flame atomic absorption instrumentation 
 
The GFAAS equipment is used for the analysis of traces of metals, given the much higher 
sensitivity. This configuraton in fact allows for the quantification of metals present in the ppb range. 
The instrumental scheme is detailed in Figure 1.22.  
 
   
Fig 1.22: graphite furnace scheme. 
 
With this technique the limit of detection is reduced, and it is also possible to perform an automated 
sequence of analyses. However, the sensitivity towards interfering substances is also increased and 
needs to be addressed in the incineration step. 
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Chapter 2 - Application of HF5-based platform to 
the production steps of novel silver nanoparticles 
 
 
 
2.1 - Application to Ag NPs synthesis  
Due to the increased use of silver nanoparticles in industrial scale manufacturing, consumer 
products and nanomedicine, reliable measurements of the size, shape and distribution of these 
particles in aqueous medium is critical since these properties affect both functional properties and 
biological impact especially in quantifying associated risks and identifying suitable risk-mediation 
strategies.  The feasibility of an on-line coupling of a fractionation technique such as hollow-fiber 
flow field-flow fractionation (HF5) with light scattering techniques such as MALS (multi-anlge 
light scattering) have been investigated for this purpose and data obtained have been compared with 
those from more conventional, but often complementary techniques e.g. transmission electron 
microscopy, dynamic light scattering, atomic absorption spectroscopy, and X-ray Fluorescence. The 
combination of fractionation and multi angle light scattering techniques has been found to offer an 
ideal, hyphenated methodology for the simultaneous size-separation and characterization of silver 
nanoparticles. The hydrodynamic radii determined by fractionation techniques can be conveniently 
correlated to the mean average diameters determined by multi angle light scattering and reliable 
information on particle morphology in aqueous dispersion can be obtained. The ability to separate 
silver (Ag+) ions from the silver nanoparticles (AgNPs) via membrane filtration during the size 
analysis can be an added advantage in obtaining quantitative insights to its risk potential. Most 
importantly, the methodology developed in this article can potentially be extended to similar 
characterization of metal-based nanoparticles when studying the functional effectiveness and 
potential hazards of these nanoparticles. 
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Materials and methods 
 
AgNPs sample 
Aqueous colloidal nanosuspension (nanosol) of silver-polyvynilpyrrolidone nanoparticles (AgNPs 4 
% wt) was provided by Colorobbia SpA (Italy).  
 
Standards 
Polystyrene nanoparticles (PS) of 50 nm and 102 nm diameter (Nanosphere Size Standards, Duke 
Scientific Corp.) were used as standards for the conformational analysis; since they are spherical 
and their structure can be assimilated to that of a random coil, a radius of gyration 
(rg)/hydrodynamic radius (rh) ratio of 0.77 is estimated. Thus the standards’ calculated rg are 
respectively 20 nm and 43 nm. 
 
AgNPs Ultrafiltration 
Ultrafiltration was carried out using Solvent-resistant Stirred Cell (Merck Millipore) with polymeric 
membrane with a pore size of 100 kDa, which was kept in slight overpressure (about 3 bar). The 
ultrafiltration system was able to retain AgNPs, while the solvent of nanosol containing synthesis 
by-products and cationic silver (Ag
+
) was removed. The vessel refilled with deionized water was 
treated for four times until the total removal of free cationic Ag
+
.  
 
HF5-UV-MALS instrumental setup 
HF5 was performed by using an Agilent 1200 HPLC system (Agilent Technologies, Santa Clara, 
CA, USA) consisting in a degasser, an isocratic pump, an autosampler and a variable wavelength 
UV detector, combined with an Eclipse® DUALTEC separation system (Wyatt Technology 
Europe, Dernbach, Germany).  
The HF5 channel (Wyatt Technology Europe) consisted of two sets of ferrules, gaskets and cap nuts 
used to seal a polymeric hollow fiber inside a plastic cartridge. The scheme of the HF5 cartridge, its 
assembly and the modes of operation of the Eclipse® DUALTEC system have already been 
described in the previous chapter. The hollow fiber was a polyether-sulfone (PES) fiber, type FUS 
0181 available from Microdyn-Nadir (Wiesbaden, Germany) with the following characteristics: 0.8 
mm ID, 1.3 mm OD, and 10 kDa Mw cut-off, corresponding to an average pore diameter of 5 nm. 
The HF5 channels used for the experimental were a standard cartridge containing a 17 cm long 
fiber. The ChemStation version B.04.02 (Agilent Technologies) data system for Agilent 
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instrumentation was used to set and control the instrumentation and for the computation of various 
separation parameters. The software package Wyatt Eclipse @ ChemStation version 3.5.02 (Wyatt 
Technology Europe) was used to set and control the flow rate values and to move the focus position 
during the sample focus/concentration. 
A 18-angle multiangle light scattering detector model DAWN HELEOS (Wyatt Technology 
Corporation, Santa Barbara, CA, USA) operating at a wavelength of 658 nm, was used to measure 
the radius of particles in solution. An Optilab rEX differential refractive index (dRI) detector 
(Wyatt Technology Corporation) operating at a wavelength of 658 nm was used on occasion as a 
concentration detector, when the capabilities of the UV detector were overcome by the complexity 
of the sample. ASTRA® software version 5.3.2.14 (Wyatt Technology Corporation) was used to 
handle signals from the detectors (MALS, and UV) and to compute the particles Rg. 
 
HF5 methods 
An HF5 method is composed of few steps: focusing, focusing-injection, elution and elution-
injection. During focusing the mobile phase is split into two different streams entering from the 
fiber inlet and outlet; during focusing-injection, the flow settings are the same described in the focus 
step while the sample is introduced into the channel through the inlet and focalized in a narrow 
region. Then, in the elution step, the flow of mobile phase enters the channel inlet and part of it 
comes out transversely (cross-flow); lastly, during elution–injection, no cross-flow is applied (the 
flow is not split anymore), allowing for any remaining sample inside the channel to be released; the 
flow is also redirected in the injection line as well to clean it before the next injection. 
The flow conditions for the different HF5 analysis are shown in Table 2.1. Longitudinal flow is 
indicated as Vc, while cross/focus flow as Vx. In so-called “flow-injection analyses” (FIA) neither 
focus nor cross-flow are applied, thus allowing all injected analytes to exit from the channel without 
retention. 
  
Table 2.1. Flow conditions for F4 analyses  
Steps   
↓Method  
Focus 
(mL/min) 
Focus-injection 
(mL/min) 
Elution 
(mL/min) 
Elution-injection 
(mL/min) 
HF5  Vc=0.35 
Vx=0.85 
Time=2 min 
Vc=0.35 
Vx=0.85 
Time=3 min 
Vc=0.35 
Vx=0.1 
Time=12 min 
Vc=0.35 
Vx=0 
Time=3 min 
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FIA  
- - - 
Vc=0.5 
Vx=0 
Time=3 min 
 
AgNPs size characterization  
 
DLS analysis 
AgNPs size distribution was determined at room temperature by Zetasizer Nanoseries (Malvern 
Instruments, UK) providing the hydrodynamic diameter of suspended particles by the DLS 
technique. The hydrodynamic diameter was expressed as D50, i.e. the median diameter at 50% in 
the cumulative distribution. DLS analysis also provides a polidispersity Index parameter (PDI), 
ranging from 0 to 1, quantifying the colloidal dispersion degree. PDI values smaller than 0,05 are 
typical of highly monodispersed standards, while values greater than 0,7 depict a broad particle size 
distribution that makes samples unsuitable for DLS analysis. A mid-range PDI value between 0,05 
and 0,7 usually ensures a proper operating condition of the instrument. As for DLS analysis, AgNPs  
were dispersed in deionized water at 0.13 mg/ml and homogenized on a vortex mixer for 30 
seconds; the resulting dispersion pH was 4,5. A small sample volume (~1 mL) was subjected to 
three consecutive measurements performed at 25° C and particle size distribution was obtained by 
averaging these measurements.  
 
TEM morphological investigation 
The observation of morphology was made using a transmission electron microscope (TEM) in 
JEOL JEM-2100F multipurpose, high resolution, electron microscope with a field emission source 
operating between 80 and 200 kV for various level of magnifications. The nanoparticles were taken 
directly from the ultrafiltered nanosol and placed on TEM grids. The samples were then left to dry 
before loading in the TEM. Particle size and distribution were determined using image processing 
software on micrographs taken at around 200 kV emission field on multiple locations within the 
sample. 
 
FAAS analysis 
An AAnalyst400 (Perkin Elmer, Massachusetts, USA) flame atomic absorption spectrometer 
(FAAS) equipped with a silver hollow-cathode-lamp, operating at 328.0 nm, was used for 
quantitative analyses of solutions collected from the HF5 cross-flow line. The instrumental 
parameters (10 mA operating current, 2.7 nm bandwidth) were adjusted according the 
52 
 
manufacturer’s recommendations. Air (10 ml/min)-C2H2 (2.5 ml/min) flame was employed. 
Ultrapure MilliQ water and nitric acid 0.5M (HNO3 for trace analysis, ≥69%, Fluka) were used to 
dilute samples or standards in all the experiments. 
Silver standard solutions, ranging from 0.2 mg/L to 5.0 mg/L, for FAAS calibration curve were 
obtained properly diluting a certificate solution of Ag (1002 ±2) mg/L (Merck, Germany).  The 
calibration curve, achieved under the best instrumental conditions, shows a good linear correlation 
(R² = 0.9972). The equation Y = 0.0211 (± 0.0003) X + 0.0040 (± 0.0009) was obtained when 
repeating the calibration 14 times. 
 
HF5 filtration of AgNPs – proof of concept  
Inductively Coupled Plasma (ICP) analysis of the aqueous colloidal suspension of the AgNPs 
characterized in this work estimates the total silver amount in 4% w/v. Part of this silver amount is 
present in its ionic form and, during the focusing-inject step of HF5 analysis, it passes through the 
hollow fiber pores. It  can be then collected and quantified.  Therefore, as a proof of concept 
solutions having cationic Ag concentrations compatible with the Ag presumably contained in the 
AgNPs sols were first injected into the hollow fiber channel. Flow rates were selected in order to 
collect Ag+ from the cross-flow line during the focusing-inject step according to the method in 
Table 2.1. During the HF5 analysis the sample is diluted almost 1:10, hence we suppose that the 
injected sol could be in the order of 4000 ppm in Ag. In order to determine the best volume fraction 
to collect from the cross-flow line, 10 µL of a solution of AgNO3 (1904 ppm) were injected into the 
HF5 system. This solution is prepared by 1:2 diluting a stock solution of 3908 ppm, obtained 
dissolving 59.94 mg (± 0.01) mg of AgNO3 in 10 ml of HNO3 0.5M.  Five aliquots of 3 ml each 
were collected from the cross-flow line, and analyzed by FAAS. For each of these aliquots, the Ag+ 
was obtained by interpolating the absorbance signal on the calibration curve. 
 
XRF 
From the ultrafiltered sample the concentration of cationic Ag present in water filtrates was 
estimated by XRF (WDS - wavelength dispersive X-ray spectrometer) using a Panalytical Axios 
Advanced (Netherlands). The XRF results showed that the ultrafiltration process allowed removal 
of 50% of Ag (compared to the initial total amount of Ag), until reaching a plateau, corresponding 
to the amount of cationic Ag at equilibrium with Ag
0
 solid phase. The results showed that about 
50% of Ag nanosol consists of nanoparticles and the remaining 50% is made of cationic Ag. 
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Results and discussion 
First a method for the size-fractionation of AgNPs was developed; it needed to be robust and 
reproducible, and able to detect AgNPs in aqueous media with a satisfactory sensitivity in particular 
with HF5.  
 
HF5- MALS of AgNPs 
Sample was separated in HF5 using water as mobile phase in order to analyze samples in their 
native formulation and to avoid potential modification due to fractionation conditions. The HF5-
MALS analysis of AgNPs obtained with flow conditions described is reported in Figure 2.1.  
 
Fig 2.1 HF5-MALS analyses of AgPVP nanoparticles in water. Light scattering signal at 90° and rg 
values determined with MALS detector are reported. 
 
The fractionation shows no void peak, expected at min 5, for the unretained species (such as 
unreacted reagents for sample preparation or small species dimensionally comparable to channel 
membrane cut-off), and a retained peak a tR=8 min typical for the nanostructure. An rms value of 
45 nm was evaluated for the NPs, with an hydrodynamic radius of about 23 nm, indicating an rg /rh 
ratio of 1.7 that is typical for rod conformation; as deeper discussed in the next paragraph 
It’s also possible to observe that when the flow field ends (tR=17 min) in the elution-injection step 
only a small LS signal is evident so all eluted samples are separated during the HF5 analysis. The 
presence of a small light scattering signal and a non significant UV signal (data not shown) indicate 
that no NPs species are released at the end of the fractionation method. As for sample 
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polydispersity, in a homogeneous (i.e., monodisperse) sample its average radius is independent 
from the averaging method. Then, the ratio between values obtained with different methods will be 
equal 1(i.e. polydispersity will equal 1). If otherwise the sample contains a mixture of species of 
different gyration radii (i.e., polydisperse sample) the average radius will depend on the averaging 
method and the polydispersity will be different from 1. In this case, the calculated polydispersity 
resulted to be 1.002, indicating that the nanoparticles are highly monodispersed. 
HF5 shows good fractionation/characterization results for NPs using water as mobile phase, having 
both a high reproducibility and a limited dilution of the sample; this allows for the determination of 
AgNPs at low concentration and for the direct collection of released metal and its quantification. 
For this purpose, in order to verify that cationic silver totally exits from the channel membrane, a 
FIA analysis and an analysis with applied cross-flow line were performed using the methods 
reported in Table 1. No UV signal at 205 nm was recorded when the field is applied, confirming 
that in the fractionation analysis cationic silver is filtered through the membrane pores during the 
focus-injection step (data not shown). 
 
Morphological analysis of AgNPs 
From the HF5-MALS analysis of AgNPs an accurate conformational analysis of samples was 
performed.  
In HF5, separation is performed between species presenting different diffusion coefficients. Being 
the diffusion coefficient of a particle directly linked to its hydrodynamic radius rh, a first 
dimensional information is obtained. MALS detection, on the other hand, allows for the calculation 
of particles’ average mean square radius rg, which depends on particle shape and compactness. By 
correlating rg and rh it is possible to determine particles shape; more in detail, a rg/rh ratio of 1.7 is 
typical for rod structures, while a ratio of 0.77-0.8 is typical for random coils as PS standards are. 
Standard PS particles were separated under the same flow conditions and mobile phase (water) in 
order to confirm the RMS radius values obtained by HF5-MALS and have a direct comparison for 
hydrodynamic radius. 
In Figure 2.2 the HF5-MALS analysis of PS standards and AgNPs is reported. 
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Fig 2.2. HF5-MALS of AgPVP nanoparticles and PS. Light scattering signal at 90° and rg values 
determined with MALS detector are reported for AgNPs (gray lines) and PS standards (brown 
lines). 
 
In the same Figure the rg values (determined from the MALS analysis) and rh values (determined 
from the HF5 analysis) are also reported. At 7 min AgNPs particles are eluted and an rg of 45 nm 
was evaluated; while at 7.8 min the 50 nm PS standard is eluted (rh =25.5nm, rg =20nm) and at 12 
min the 102 nm PS standard is eluted (rh =51nm, rg =46nm). 
A ratio of rg / rh = 1.7 was calculated suggesting a chain shape. The HF5-MALS morphological 
analysis suggests the presence of small aggregates of Ag nanoparticles in a chain arrangement, as 
confirmed also by TEM observation discussed in the subsequent section. 
A chain shape is not very common among these materials, although some synthesis methods to 
form Ag nanowires in solution-phase and PVP presence have been presented 
80
, but this could also 
be related to the lack of descriptivity obtainable with DLS, which factors in the hydrodynamic 
radius alone, and TEM, where the analysis can be biased by sample handling. In fact, being this 
morphology related to an aggregation state, a soft technique like field-flow fractionation can show 
the real appearance of the sample since there are no stabilizers (like surfactants or additives which 
constituted the formulate) and stressful steps are avoided. A tendency to form chain-like aggregates 
is however noticeable in TEM analyses, although it does not concern all the particles, as later 
discussed. 
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Size characterization 
Figures 2.3a and 2.3b show the particle size distribution by Intensity and by Volume of AgNPs after 
ultrafiltration obtained from DLS analysis.  
 
 
Fig 2.3. DLS Particle size distribution by Intensity (a) and by Volume (b) for ultrafiltered AgPVP 
nanoparticlesdispersed in water at 0,13 mg/ml (pH = 4,5).  
  
From cumulants analysis, the mean hydrodynamic diameter (or Z-average), rh of AgNPs has been 
measured to be around 100 nm with a PDI of 0,24.  However for samples characterized by a 
multimodal size distribution, the Intensity particle size distribution should be considered for the 
assignment of the size of each peak. AgNPs sample shows a bimodal size distribution with peaks 
centered on 140 (Peak1, %PD=43) and 20 nm diameter (Peak2, %PD=14). The intensity size 
distribution are really sensitive to the presence of aggregates and large particles, because scattered 
light intensity is proportional to the sixth power of their diameter, thus to estimate the relative 
amount of each peak in the distribution, the Volume particle size distribution has been considered. 
From this latter, the relative volume of the two populations at 140 and 20 nm resulted almost the 
same, being respectively 49% and 51%. 
Figure 2.4 shows the typical morphology and the distribution of AgNPs obtained from transmission 
electron microscopy.  
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Fig 2.4. TEM micrograph (over) and a histogram of the mean diameter of sample AgNPs after 
ultrafiltration (below). 
 
The sample is polydispersed and the particle size histogram follows a skewed Gaussian distribution 
with a long tail towards larger particle size than the average particle size lying around 15-20 nm. 
Interestingly, the morphology shows that while larger size aggregates (>40 nm, but on an average 
~100 nm) are more or less isolated the smaller size particles (<40 nm, but on an average ~15-20 
nm) have a tendency to be linked to the extent of forming a chain shape aggregate. The latter 
observation agrees with data obtained from HF5-MALS method. The inherent nature of the 
differences in sample state and preparation technique must be taken into account when data from 
these entirely different techniques are compared especially for TEM for which samples had to be 
sufficiently dry to allow this high vacuum microscopy technique, pressure typically better than 10
-6 
Torr, to work.  
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Ag release 
After the development of an HF5-MALS method for the characterization of AgNPs, its potential as 
an analytical step useful to the study of biological impact of NPs through the quantification of 
released metal in the environment was explored. 
Purification from reagents of the AgNPs synthesis via membrane filtration during the focus-
injection step of the analysis, and determination of silver release from AgNPs were then performed. 
A schematic view of the proposed method able to size separate NPs and isolate cationic Ag fraction 
is reported in Figure 2.5.   
 
Fig 2.5: Schematic view of an on-line, one-step Ag+ filtration and particles purification with HF5: 
(a) Cationic Ag filtration during focus-injection and NPs relaxation, (b) AgNPs size-separation and 
fractions collection 
 
Some experiments were performed in HF5 system in order to define operative conditions to 
quantify, with a good recovery, the ionic silver contained into a sample of nanoparticles synthesized 
by an industrial process. The standard solution of AgNO3 (1904 ppm) was analyzed with the HF5 
method (cationic Ag collection) reported in Table 2.1. Five aliquots of 3 ml were collected from 
cross-flow line and analyzed by FAAS. For each one, silver concentration was obtained by 
interpolation of absorbance signal on the calibration curve. FAAS measurements indicated that a 
volume of 12 mL must be collected since silver content of the latter fractions was under the limit of 
detection (data not shown). The results showed the recovery of cationic silver was higher than 90% 
confirming that these conditions allow maximizing recovery of cationic silver collected from the 
cross-flow line through HF5 membrane.  
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These experimental conditions were applied to dose cationic silver in a sample of AgNPs diluted 
1:10 from batch. FAAS measurements indicated that the ionic silver amount in the sample is about 
50% of the total. This value is consistent with the cationic Ag concentration determined, by XRF 
analysis, in samples obtained after the ultrafiltration process. 
Such result confirms the capability of HF5 technique in one-step process to separate ionic phase 
from solid one, allowing for a better correlation between physicochemical properties and biological 
reactivity. A more sound comprehension of nanospecific biological reactivity in fact will support 
mechanistic studies and allow the control of nanophase reactivity by playing with surface 
engineering (safety by design approach). 
 
Conclusions  
On-line coupling of /HF5 with MALS appears to be an ideal, hyphenated methodology for the 
simultaneous size-separation and characterization of AgNPs samples because they provide 
independent size information. The rh values determined by AF4/HF5 can be correlated to the rg 
values determined by MALS and information on particle shape and morphology can be obtained. 
All the analysis can be performed in aqueous media providing fundamental information regarding 
the actual state of aggregation, size and shape of nanoparticles in physiological media. This leads to 
more realistic assessment of the risk posed by AgNPs to health, safety and the environment. In 
addition, the ability to separate the Ag
+
 ions from AgNPs during the size analysis can be 
advantageous in providing further quantification of its potential risk, which largely originate from 
the release of Ag
+
 ions. Overall, the combinatorial approach described in this subchapter may 
significantly improve the characterization of metal-based nanoparticles in order to study both their 
functional effectiveness and potential hazards.  
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 2.2 - Application to Ag NPs optimization and coating evaluation 
 
In this subchapter HF5 is coupled on-line with Multi-Angle Light Scattering (MALS) for the 
development of  methods for the characterization of NPs as quality control in new pharmaceutical 
field.  The HF5-MALS was applied to the size characterization in different preservation conditions 
of silver polyvynilpyrrolidone-stabilized NPs (AgPVP) used for their antimicrobial activity. The 
ratio of gyration and hydrodynamic radii of AgPVP was evaluated for fresh and aged NPs, 
suggesting in this case aggregation rearrangement. The influence of different PVP coating and 
dilution factor was also studied. Finally the metal ion release was determined in relationship to 
these shape modifications. The HF5-MALS method is robust and reproducible and it can be 
considered as an important tool for the development of analytical platform for quality control of 
NPs. 
 
Materials and methods 
AgNPs sample 
In this work, five different preparations of Ag NPs have been analysed. 
Aqueous colloidal nanosuspension (nanosol) of polyvynilpyrrolidone(PVP)-stabilized silver 
nanoparticles (AgNPs 4 % wt), provided by Colorobbia SpA (Italy), named Ag PVP1. 
PVP-coated silver nanoparticles (Ag PVP at different concentrations): 0.3% and 0.03% Ag wt (the 
latter one obtained by diluting the sol immediately after the synthesis) were obtained by ISTEC-
CNR Faenza through patented synthesis 
81
 and were named Ag PVP2 and Ag PVP3 respectively. 
AgPVP@SiO2: 0.12% and 0.012% Ag wt (the latter one obtained by diluting the sol immediately 
after the synthesis) named Si-AgPVP1 and Si-AgPVP2 respectively. The silica modified sample 
was prepared mixing silver and silica NPs in well-defined weight ratio (Ag:SiO2 1:1) and then ball 
milling for 24 hours (milling media, 3 mm zirconia spheres). Through colloidal approach, 
heterocoagulated Ag:SiO2 sample was obtained exploiting electrostatic interactions between 
negatively charged silica nanoparticles and positively charged silver ones. The sample was 
morphologically characterized by transmission electron microscopy (TEM). One drop of 
heterocoagulated sample, diluted in deionized water, was deposited on a film-coated copper grid 
and then air dried. The sample was examined by FEI titan TEM operating at an acceleration voltage 
of 300 kV. Moreover, elemental analysis was performed by combining XRD analysis (Energy 
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Dispersive X-ray – EDX). The EDX analysis was carried out in order to qualitatively estimate Ag 
and Si element.  
 
HF5-UV-MALS.  
The instrumental set-up has been already described in subchapter 2.1.  The Hydrodynamic radiuses 
were calculated according to a method calibration performed with PS standards analysed in the 
same conditions. 
 
HF5 methods 
The HF5 methods used for particles characterization and ionic fraction collection are reported in 
Table 2.1, Chapter 2.1. A volume of Ag NPs in the 0.5 to 5µl range was injected for the 
characterization of the sample in order to avoid saturation of the scattering signal, while a volume 
of Ag NPs of 100 µl was injected to collect the ionic fraction.  
  
 
Ag+/Ag determination.   
The method reported in Table 2.1 was used to collect Ag
+
 ions during the injection/focusing step; 
then, the Ag+/Ag ratio was determined in Milli-Q water through the quantification of ionic Ag with 
Flame Atomic Absorption Spectroscopy (FAAS). The proof of concept of the efficacy of this 
method has already been demonstrated in Chapter 2.1 
57
. This is a non-destructive method, allowing 
for the collection of filtered nanoparticles that can be therefore tested individually to investigate 
particle-specific activity. A volume of 10ml was collected from the HF5; 1ml of concentrated 
HNO3 was added. The concentration of Ag+ was determined with FAAS by interpolation on a 
standard calibration curve. Each quantitative analysis was repeated three times.  
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Results and discussion 
 
HF5-MALS for stability studies 
The HF5-MALS method developed and described in Chapter 2.1 was usd for the stability study of 
nanoparticles over time and in different media. For consistency, all the analyses have been carried 
out with the same method cited in the Materials and Methods section of the previous chapter. 
 
Influence of ageing onto shape modification 
The first sample to be analysed was Ag PVP1. The same sample was (1) diluted 1:10 prior to 
injection and immediately analysed or (2) left to age at room temperature and away from light 
sources for three weeks. 
The HF5-MALS characterization of Ag PVP1 obtained with flow conditions is reported in Figure 
2.6, where the two analyses are overlaid.  
 
Fig 2.6. Overlay of Ag PVP1 fractograms (LS signal, black and grey lines) and calculated gyration 
radi (black and grey segments) in milliQ water for freshly prepared (1) and aged (2) Ag PVP1 
samples. Y axis refers to gyration radius (nm), while x axis is time (min).  
 
In both fractograms the fractionation shows no void peak, expected at 5 min, for the unretained 
species (such as unreacted reagents for sample preparation or small species dimensionally 
comparable to channel membrane cut-off), and a retained peak a tR = 7.9 min.  
An rg value of 45 nm was evaluated for the fresh NPs, with a hydrodynamic radius of 23 nm, 
indicating an rg/rh ratio (shape factor) of 1.7 that is typical for rod conformation (see materials and 
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methods), while an rg radius of 25 nm was measured for aged nanoparticles, indicating a different 
arrangement of the (rg/rh = 1.1, corresponding to an elongated/ovoidal structure)
34
 
64
. This 
modification in shape suggests also that nanoparticles aggregate in suspension with a specific 
arrangement, since only one band (hence one population) was observed for each analysis, and that 
this arrangement depends on the suspension characteristics (dilution, ageing..). Hydrodynamic radii 
were determined through a calibration procedure, as already described 
55
 
82
.
 
It is interesting to notice that the hydrodynamic radius of the particles aggregated system remained 
unvaried; such a variation in shape then would have remained undetected with dynamic light 
scattering, whereas a combination of in-batch techniques would have been effective only in the case 
of monodispersed samples and the information provided wouldn’t have been employable for sorting 
purposes. In case of testing for toxicity, for example, particles shape influences the overall toxicity 
83
, and since aggregated particles can be considered as interacting systems themselves this could 
cause a mismatch between properties and toxicological data. 
 
Shape determination in complex media 
Since Ag NPs are meant to be facing different conditions over the course of their synthesis, 
stockage and pharmaceutical usage, the analyses were extended to a more complex medium, closer 
to the conditions in biological carriers (formulation buffers and physiological conditions). 
In order to understand the behaviour of Ag PVP1 in this scenario, analyses were performed using an 
electrolyte-rich carrier (phosphate buffer 0.1M) and compared with the same analysis performed in 
MilliQ water. Two polystyrene (PS) standards of 51 and 102 nm as diameter were also injected. 
They provided a direct ruler for the determination of the hydrodynamic radius. In Figure 2.7 the 
HF5-MALS analyses are reported. 
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Fig 2.7. Overlay of size markers (PS particles 51 nm-band 2, 102 nm-band 3) and Ag PVP1 (band 
1) fractograms in PBS. Y axis refers to gyration radius (nm), while x axis is time (min). Red (PS) 
and grey (Ag PVP1) lines are the scattering signal at 90°, while the 1, 2, 3 segments are the 
calculated rg 
 
Results were compared to the characterization of the same sample previously performed in MilliQ 
water.  
For the analysis in phosphate buffer, at 18.9 min Ag PVP1 particles are eluted and a rg of 29 nm 
was evaluated; while at 15 min the 51 nm PS standard is eluted (rh = 25.5 nm, rg = 20 nm) and at 
21.4 min the 102 nm PS standard is eluted (rh = 51 nm, rg = 46 nm). The sample displays a higher 
hydrodynamic radius, calculated with size markers 
84
, while still maintaining the same gyration 
radius. rg/rh ratio is 1.7 for Ag PVP1 in water (rg= 45nm, rh =25) and 0.7 for PBS (rg=29nm, rh 
=41.4nm), suggesting a rearrangement in a dense, spherical agglomeration due to the presence of 
electrolytes. The presence of salt in fact favors an aggregation process, which has been studied by 
Huyhn et al 
85
 where an increase of hydrodynamic radius over time was detected. However, in the 
cited work no assumptions have been made with regard to the aggregates shape, which is indeed a 
key factor in particles effect upon exposure 
86
. 
 
Influence of coating vs dilution  
To further customize and tune the activity of Ag NPs a multilayered approach can be used 
87
. A 
known strategy is to coat them with silica by further layering on a functionalised surface with 
synthetic polymers as PVP, which can provide a stabilization mechanism for successful silica-
coating 
88
. This kind of coating is porous, and can create an hydrophilic surface further stabilising 
the nanoparticle suspension because of the increased negative charge; moreover, it offers a platform 
for further functionalisation of biocompatible nanoparticles 
89
 and does not hinder optical properties 
of the nanoparticles since silica shells protect the surface plasmonic resonance (SPR) 
90
. Last, for 
antiseptic applications, a porous surface would limit the release of ions (hence the particles 
dissolution) without blocking it (therefore mantaining their acute effect), enhancing the life of these 
materials to facilitate their access to biological membranes. 
The morphological characterization on the silica-modified sample showed Ag NPs randomly 
distributed within the silica matrix, as expected from the colloidal approach  
91
. The structure 
showed the Ag nanoparticles surrounded by the SiO2 phase (Fig. 2.7a-c). The presence of Ag and Si 
was confirmed by EDX analysis (Fig. 2.7c), showing the presence of SiO2 coating -consisting of 
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NPs- on Ag NPs in a nanomatrix structure, visible in Figure 2.7b, as a consequence of the 
interaction between the two phases.  
 
Fig 2.7. a) and b) TEM images and c) and d) EDX analysis on SiO2 modified Ag sample obtained 
using the colloidal approach (heterocoagulation). 
 
To verify the effect of this treatment onto Ag NPs, the physicochemical properties in the native 
(undiluted) and diluted state were compared, in order to better understand the dynamics of ionic 
release (described in detail in the following section) of the four samples Ag PVP2, Ag PVP3, Si-
AgPVP1 and Si-Ag PVP2.  
The analyses overlaid in Figure 2.8 showed no void peak, a weak signal at 7 min (possibly PVP 
excess) and a very low signal at 17.5 min, when the crossflow is released.  
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Fig 2.8. Fractograms and calculated gyration radii of Ag PVP2 and Ag PVP3 (black) and Si-Ag 
PVP1 and Si-Ag PVP2 (green). 1. is the gyration radius found for undiluted samples, while 2. is the 
gyration radius found for ten-fold diluted samples. 
 
Both the undiluted (Ag PVP2) and the diluted (Ag PVP3) PVP-coated nanoparticles are eluted at 8 
min, with a hydrodynamic radius of 25 nm. Their gyration radii however differ of a factor 2, since 
the rg found for Ag PVP2 is 37.6 nm and the one found for Ag PVP3 is 17.9 nm. Consequently, the 
rg/rh ratios are 1.50 and 0.72, respectively.  
The retention time for Si-AgPVP1 and Si-AgPVP2 was 8.1 min in both cases, corresponding to a 
hydrodynamic radius of 25.5nm. Again the gyration radii showed the same trend and were found to 
be 44.8 nm for the undiluted sample and 21.2 nm for the diluted sample. Consequently, the rg/rh 
ratios are 1.75 and 0.85, respectively.  
Therefore, both the concentrated samples (Ag PVP2 and Si-Ag PVP1) displayed a rod-like 
conformation, while the diluted samples were spheroidal: even though the presence of the silica 
coating should provide a higher stability towards dissolution, the dilution effect on agglomerates 
shape is prevailing. 
In addition, the all the PVP-NPs show high injection-to-injection reproducibility and no peaks were 
observed at the field release suggesting that no NPs are retained to the fiber (data not shown). 
 
Investigation of ion release mechanism and relationship with shape modification 
The speciation of nanoscale objects, namely, their detection and separation based on the different 
species is of outmost importance, since different particle size/shape population and distribution 
between particle size and the percentage of the dissolved fractions may have a strong impact on 
toxicity and fate 
92
. Moreover, for metal-based nanoparticles there are different uptake mechanisms 
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for “nano” and ionic metal. The main techniques used for speciation analysis are inductively 
coupled plasma mass spectrometry (ICPMS), graphite furnace atomic absorption spectrometry, 
inductively coupled plasma optical emission spectrometer (ICPOES), or chromogenic methods 
93
. 
These procedures however are incapable of distinguishing the elemental form from the nanoparticle 
form: more recently, they have been employed following a separation step, such as dialysis, 
ultracentrifugation, chromatography and flow field-flow fractionation. However, non-destructive 
protocols for nanoparticle sorting and simultaneous quantification are, though existing 
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58
, limited 
to some applications/samples or still at a pre-market level.  
With the method described, Ag ions were selectively collected and quantified. The ionic silver 
amount, expressed as mass percentage on the total silver content, is listed in Table 2.2. 
 
Sample % Ag
+
 Δ% Agwt 
Ag PVP2 55 1 
Ag PVP3 40 1 
Si-Ag PVP1 48 3 
Si-Ag PVP2 34 3 
Table 2.2. Free ions percentage measured for the four Ag NPs analysed.  
 
To verify the lack of Ag
+
 ions sample loss, a critical point in fractionation analyses, 
94
 a series of 
injections of stock solutions of AgNO3 have been analysed with the above described method and 
the fractions collected have been quantified through Flame Atomic Absorption, giving a recovery 
>99%. 
The undiluted and the diluted Ag PVP samples were found to have a concentration of free Ag
+
 of 
55 and 40% w/w respectively, while the corresponding Silica-coated samples contained an amount 
of ionic silver corresponding to 48 and 34%.  
From these results one can notice that the concentration of free Ag
+
 is lower for the diluted samples, 
and that this trend is found similar for the two materials, even when the presence of the Silica 
coating should have shielded the nanoparticles thus imposing a lower percentage of Ag
+
. 
When nanoparticles are diluted, the buffer modification induces a change in the morphology of the 
aggregates present in suspension. Therefore, a new equilibrium between particles and ions is likely 
to form, since the “nanoparticle-ion” system is a dynamic one 95. This does not imply automatically 
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a higher release of ions for diluted samples; indeed for a chain-shaped system (concentrated 
samples) the surface-volume ratio is higher than that of a spherical/globular system (diluted 
samples), allowing to maximize the particles interaction with the medium. Conversely, when 
samples are diluted they tend to limit the surface available for this equilibrium, as summarized in 
Figure 5.  
 
Fig 2.9. Interpretation of similarities between Ag PVP and Si-Ag PVP particles. The undiluted 
samples displayed a similar chain-like conformation (as symbolized on the left of the table), while 
the diluted ones presented agglomerates of spherical morphology (right side). Grey: representation 
of Ag NPs. Red and blue: representation of silica-coated Ag NPs. 
 
A plausible explanation for this behavior resides in the nature of these species: the polymer 
template acts as a necklace for the Ag NPs and its arrangement is what influences the overall 
morphology. When the colloidal equilibrium is altered – were it for ageing, dilution, or buffer 
modification – the system collapses and coils, thus shielding the particles and subtracting them from 
the interacting surface
96
 
97
. 
The shape-ion release correlation is confirmed for both samples. On the other hand, the presence of 
a porous coating of SiO2 limited the ion release of about 7% when comparing Ag PVP2 and Si-Ag 
PVP1, and about 6% when comparing Ag PVP3 and Si-Ag PVP2.  
Consequently, the use of an HF5-based platform could give information about many parameters at 
the same time, offering a tool for the study of shape-behaviour relationships for nanosized samples. 
This data is particularly relevant in the quality assessment of nanoparticles, where size and shape 
play an important role in their activity and toxicity 
21
. Likewise, the effect of a further silica coating 
can be monitored and quantified. 
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Conclusions 
 
In this work, an ad hoc method based on HF5-MALS was developed for silver NPs characterization 
in terms of size, shape and metal release. These parameters have been assessed in different media 
(water and electrolyte-rich medium) to highlight the conformational modifications particles undergo 
when are exposed to mediums different from stock solution and stabilizing agents. Moreover, the 
effects of ageing and coating with silica on aggregation rearrangement were also shown. Lastly, the 
concentration- and coating-dependent ion release has been quantified, suggesting that diluted 
sample regardless of PVP coating have an spherical/globular shape which limits the interactions 
with medium thus showing a lower concentration of free silver ions. This presented method has an 
high reproducibility and it can be considered as multiparametric as a promising tool toward the 
quality control of nanoproducts. 
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Chapter 3 - Integration of the analytical platform to 
address safety concerns towards Ag NPs 
 
 
Silver nanoparticle-based antimicrobials can promote a long lasting bactericidal effect without 
detrimental toxic side effects. However, there is not a clear and complete protocol to define and 
relate the properties of the particles (size, shape, surface charge, ionic content) with their specific 
activity. This chapter focuses on bringing forward an effective multistep approach for the 
identification of a “purpose-specific active applicability window” to maximise the antimicrobial 
activity of devices containing silver nanoparticles (e.g. wound dressing, dental paste, or surface 
coaters), minimising any consequent risk for human health (safety by design strategy). The 
antimicrobial activity and the cellular toxicity of four types of Ag NPs, differing in their coating 
composition and concentration (i.e. polyvinylpyrrolidone, citrate and hydroxyethylcellulose) have 
been quantified. Through the implementation of flow field-flow fractionation, Ag NPs have been 
characterized in terms of metal release, size and shape. The particles are fractionated in the process 
while being left unmodified, allowing for the identification of biological particle-specific 
contribution. Toxicity and inflammatory response in vitro have been assessed on human skin 
models, while antimicrobial activity has been monitored with both non-pathogenic and pathogenic 
Escherichia coli in real time.  
The main benefit associated with such an approach is the comprehensive assessment of the maximal 
effectiveness of candidate nanomaterials, while simultaneously indexing their properties against 
their safety.  
The application of an active antimicrobial nanomaterial in the healthcare industry can decrease the 
cost of Healthcare Associated Infections, often due to MRSA, that weight for a loss of 7bln € in 
Europe and 6.5bln € in the US (source: WHO). 
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Materials and methods 
 
Silver nanoparticles.  
For this study four different silver nanoparticles suspensions (Ag NPs) have been employed. Ag 
Pristine (0.02 wt% silver concentration) was provided by Colorobbia SpA (Italy). 
Polyvinylpyrrolidone-coated sample (Ag PVP, 0.02 wt% silver concentration), Citrate-coated 
sample (Ag CIT, 0.02 wt% silver concentration) and Hydroxyethyl cellulose-coated sample (Ag 
HEC, 0.02 wt% silver concentration) were synthesised in ISTEC-CNR (Faenza, Italy). Pristine and 
Ag PVP were obtained within the same process on a different scale (industrial scale for the Pristine, 
lab scale for the PVP coated material) using the same reducing (glucose) and capping 
(polyvinylpyrrolidone) agents but an excess of polyvinylpyrrolidone for the industrial scale 
synthesis 
81
. Ag CIT was obtained using sodium citrate (Sigma Aldrich) both as reducing agent and 
as a stabilizer, starting from AgNO3 solution. The synthesis reaction occurred in basic 
environmental and at 70°C by microwave heating, which it enables homogeneous heating and rapid 
achievement of the desired temperatures
98
. The Ag HEC was synthesized, at room temperature, 
reducing a solution of AgNO3 by hydroxyethyl cellulose which was also used as capping agent. The 
reduction synthesis was catalysed by NaOH (Sigma Aldrich). 
99
   
 
HF5-UV-MALS.  
HF5 analyses were performed using the same setup described in Chapter 2.1. 
A volume of Ag NPs of 5µl was injected for the characterization of the sample in order to avoid 
saturation of the scattering signal, while a volume of Ag NPs of 100 µl was injected to collect both 
the ionic fraction and the isolated nanoparticles. Multi-angle laser light scattering was used to 
determine colloidal size. It allows for the determination of particle root mean square radius of 
gyration (Rg) by measuring the net intensity of light scattered by such particles at a range of fixed 
angles. The particle Rg is determined by the mass distribution within the particle. The single mass 
increments are weighted by the square of the radius distance from the center of mass. Consequently, 
two particles with same hydrodynamic radius (Rh), but with different Rg values, may have a 
different mass distribution, and thus, different shapes. Combining the two sizing techniques via 
Rg/Rh ratios, a shape factor is obtained, reflecting the compactness and shape of the particles. For 
example, this corresponds to a value of 0.77 for a compact sphere and increases to about 4 for 
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needle-like conformation, or decrease to about 0.6/0.5 for particles presenting a hard core and a soft 
shell/coating. 
Ag
+
/Ag determination.  
The Ag+/Ag ratio was determined in Milli-Q water, analysing samples through an ad-hoc analytical 
method listed in Table 2.1, able to retain Ag NPs and filtrate away Ag
+
 ions. The subsequent 
quantification of ionic Ag with FAAS was used to estimate the Ag+/Ag ratio. This is a non-
destructive method, allowing for the collection of filtered nanoparticles that can be therefore tested 
individually to investigate particle-specific activity. In this work, since the preliminary 
determination of Ag
+
 through FAAS showed a very low concentration of Silver, Graphite Furnace 
was used instead. To quantify the ionic fraction a volume of 10 ml was collected, 1 ml of conc. 
HNO3 was added and the concentration of Ag
+
 was determined with atomic absorption 
spectroscopy by interpolation on a standard calibration curve (LoD = 0.2ppb) following opportune 
dilution. Pd and Mn(NO3)2 were used as modifiers to prevent analyte loss. Each quantitative 
analysis was repeated three times and the ionic silver amount, expressed as percentage on the total 
silver content, is listed in Table 3.1. By subtraction, the amount of “nano” silver present in the 
collected nanoparticles was obtained and by correlating it with the fraction volume the subsequent 
concentration was determined. 
Nanoparticle Tracking Analysis (NTA).  
The average hydrodynamic radius of silver nanoparticles in water was characterized using 
Nanoparticle Tracking Analysis (NTA) developed by Malvern Instruments Limited (Wiltshire, 
UK). This technique utilizes the properties of light scattering and Brownian motion to obtain 
particle size distributions of samples in liquid suspension 
100
. A NS500 instrument, equipped with a 
405 nm laser in conjunction with software version NTA 3.1, was used for the purpose of this study. 
Silver nanoparticles at the concentration of 200µg/ml in Milli-Q water were vortexed for 5 s to 
disperse the particles and then diluted at 0.2 µg/ml. The four different dispersions were then 
analyzed via NTA for the measurement of hydrodynamic diameter at room temperature. All 
measurements were carried out three times in MilliQ water to match the Rg determination. Results 
are reported as average mode ± standard deviation. 
Zeta potential.  
Zeta potential of Ag NPs (200µg/ml), diluted 10 fold in Milli-Q water and Dulbecco's Modified 
Eagle Medium (DMEM), were evaluated using a Zetasizer Nano Z (ZEN5600, Malvern 
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Instruments, UK). Three zeta potential measurements were taken for each sample, each made of 20 
accumulations. Measurements were carried out at 25 °C, and elaborated using Smoluchowski 
model. 
Transmission Electron Microscopy (TEM).  
A Jeol 2100 Transmission Electron Microscope (USA) was used to image the Ag NPs, with sizes of 
the Ag NPs being calculated using Image J software 
101
. A droplet of each preparation was 
deposited on a glass slide and left for 30minutes. Then a grid was dragged onto the droplet surface 
to collect the nanoparticles, which accumulate on the droplet surface because of the superficial 
tension. Each grid was left to dry and then analyzed.  
Incubation with the Ag NPs.  
Silver nanoparticles dispersed in a stock solution at a concentration of 200 µg/ml in Milli-Q water 
were diluted in the following way: for the cell treatments they were diluted in medium to reach the 
desired range of concentrations (2.5-100µg/ml), whereas for the antibacterial activity they were 
diluted in Milli-Q water to reach a range of concentrations from 0,625 to 100µg/ml.  
Antibacterial activity testing  
The antibacterial effect of the nanoparticles was tested against Escherichia coli. E. coli strain 
TOP10 or CFT073 harbouring plasmid pGen-Lux 
102
 was incubated with various concentrations of 
nanoparticles over a time course of up to seven days. Plasmid pGen-Lux encodes the lux operon 
from Photorhabdus, the gene products of this operon imparts bioluminescence specifically on viable 
bacteria. One relative light unit (RLU) is approximately equal to 100 viable bacteria.  Dead or non-
viable bacteria are non-luminescent. All nanoparticles were tested up to a concentration of 100 
µg/ml and were found to be non-luminescent, thus the effects of the particles on bacterial viability 
were amenable to measurement by luminometry. Bacteria were cultured at 37
o
C with shaking at 
200 rpm in L Broth (Sigma, St Louis, MO, USA) to mid-logarithmic phase. 50 µl aliquots of mid-
logarithmic cultures (equivalent to ~10
6
 cells) were incubated with an equal volume of the requisite 
nanoparticles in Lumitrac 200 96 well plates (Greiner).  MilliQ H20 was used as a negative control. 
Luminescence was read in a Thermofisher Luminoskan™ Ascent Microplate Luminometer 
(Dublin, Ireland). Each concentration was tested in duplicate, and the experiment was repeated three 
times. The RLUs of untreated samples were normalised top 100% and treated samples were 
adjusted accordingly.  
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Cell Culture and experimental treatments.  
The viability tests after exposure to Ag NPs preparations were performed onto A431 (human 
epidermoid carcinoma) and HaCaT (human keratinocytes) cell lines representative of human skin 
models. A431 cells were obtained from ATCC (LGC Standard, UK) and cultured in Dulbecco’s 
modified Eagle’s medium (DMEM High Glucose) supplemented with 10% FBS, 2mM L-
glutamine, streptomycin (100 μg/ml) and penicillin (100 U/ml). HaCaT cells, obtained from ATCC 
(LGC Standard, UK), are cultured in Dulbecco’s modified Eagle’s medium (DMEM Low Glucose) 
supplemented with 10% FBS, 2mM L-glutamine, streptomycin (0.01 µg/ml) and penicillin (0.01 
U/ml). Cells were routinely cultured in a humidified atmosphere of 5% CO2 in air in T75 cell 
culture flasks (Nunc, Fisher Scientific, Dublin, Ireland) For cytotoxicity experiments and ELISA 
assay, cells were seeded in complete growth medium on Nunc-96-well multiwell plates, at a density 
of 10×10
3
cells/well and 20×10
3
cells/well, for A431 and HaCaT, respectively. For the recovery 
experiments cells were seeded in complete growth medium on Nunc-96-well multiwell plates, at a 
density of 2×10
3
cells/well and 4×10
3
cells/well, for A431 and HaCaT, respectively. After 24 h, the 
growth medium of the cells was replaced with Ag NPs prepared as previously described. FBS was 
not employed for this stage to avoid the formation of artefact through protein corona effects. Doses 
of NPs were adjusted so as to obtain a silver concentration range from 4 µg/cm
2
 to 160 µg/cm
2
 
(corresponding to a range from 2.5 µg/ml to 100 µg/ml).  
For the particle specific activity, the doses used were adjusted to obtain a final silver concentration 
of 5, 10, 20 µg/ml for Ag Pristine, 5, 10, 15 µg/ml for Ag PVP and 4, 6, 8 µg/ml for Ag HEC, 
corresponding to 3.12, 6.24, 12.48 µg/cm
2
, 3.12, 6.24, 9.36 µg/cm
2
 and 2.5, 3.75 and 5 µg/cm
2
 
respectively. Since the fractionation led to dilution of the preparation, lower concentrations of total 
silver were used to assess toxicity. After 24h exposure cell viability was assessed using calcein 
assay. In all the experiments, vehicle (1:1, Milli-Q water: DMEM) was added as negative control. 
Calcein assay.  
Live cells are distinguished by the presence of ubiquitous intracellular esterase activity, determined 
by the enzymatic conversion of the virtually nonfluorescent cell-permeant calcein AM to the 
intensely fluorescent calcein. The polyanionic dye calcein is well retained within live cells, 
producing an intense uniform green fluorescence in live cells. After 24h of incubation in the 
presence of Ag NPs, cell viability was tested replacing medium with a solution of calcein (1 mM) in 
serum-free medium. After 45 min of incubation at room temperature, protected from the light, 
fluorescence was read at 635 nm with Epoch microplate reader (Epoch, BioTek, UK). Since 
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nanomaterials could interfere with this assay, a preliminary experiment was performed incubating 
both dyes with Ag NPs preparations at the highest concentration used (100µg/ml). No fluorescence 
signal was detected above the background signal. 
Resazurin assay.  
Resazurin is a substrate that changes colour in response to metabolic activity. It is a non-fluorescent 
molecule converted by intracellular enzymes in the fluorescent compound resorufin (λem = 590 
nm). After 24h of incubation in the presence of Ag NPs, cell viability was tested replacing medium 
with a solution of resazurin (44 mΜ) in serum-free medium. After 1 hour of incubation, 
fluorescence was measured at 604 nm with Epoch microplate reader. Also in this case we 
performed a preliminary experiment to test the interference of silver nanoparticles with resazurin 
assay. No fluorescence signal was detected above the background. 
LDH Cytotoxicity assay.  
Lactate dehydrogenase (LDH) is a cytosolic enzyme present in many different cell types. Plasma 
membrane damage releases LDH into the cell culture media. Extracellular LHD in the media can be 
quantified by a coupled enzymatic reaction in which LDH catalyses the conversion of lactate to 
pyruvate via NAD+ reduction to NADH. Diaphorase then used NADH to reduce a tetrazolium salt 
(INT) to a red formazan product that can be measured at 490nm. The level of formazan formation is 
directly proportional to the amount of LDH released into the medium, which is indicative of 
cytotoxicity, and was determinate with. Pierce LDH Cytotoxicity Assay kit (Thermo Scientific, 
UK). In summary, after 24 h of incubation with Ag NPs, 50 µl of medium were transferred to a 96-
well plate. Then, 50 µl of Reaction Mixture (contained in the kit) was added to each sample and, 
after 30 min of incubation at room temperature, 50 µl of Stop Solution were added. The absorbance 
was read at 490nm and at 680 nm. To determinate the LDH activity, the value of absorbance at 680 
nm (background) was subtracted from the 490 nm absorbance before calculation of % Cytotoxicity. 
Total LDH Activity (Maximum LDH Release Control activity) was used as positive control and 
was performed by adding 10X lysis buffer (contained in the kit) to the cells: 
% Citotoxicity =
Ag NPs − treated LDH activity
Maximum LDH activity
∗ 100 
Cytokine secretion.  
After 24h of incubation with Ag NPs, the presence of Tumor Necrosis Factor-alpha (TNF-α), 
Interleukin-6 (IL-6), Interleukin-8 (IL-8) and IL-1β in the culture media of the A431 and HaCAT 
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cells was determined with ELISA Biolegend standard sets (Biolegend, Inc., San Diego, USA). 100 
µl of medium were transferred into 96-well plates, previously functionalized overnight with anti-
cytokine antibodies, and incubated for 2 hours at room temperature (RT). Then 100 µl of diluted 
Detection Antibody were added in each well and, after 1 hour of incubation at RT, 100 µl of diluted 
Avidin-HRP were added. After 30 min, samples were incubated with 100 µl of TMB Substrate 
Solution, contained in the kit; after 30 min, reaction was stopped and absorbance was immediately 
read at 450 nm with a plate reader. Standards were performed in the assay diluent from a solution of 
50 ng/ml of the recombinant cytokine, as for manufacturer’s protocol. 
Reagents.  
FBS and culture media were purchased from Sigma Aldrich (Dublin, Ireland). Calcein was 
purchased from Molecular Probes, Invitrogen (Dublin, Ireland). ThermoFisher (Dublin, Ireland) 
was the source of all the other chemicals, whenever not specified otherwise. 
Statistics. Statistic evaluation of effects has been performed with One-way ANOVA with 
Bonferroni test. Statistics have been performed using GraphPad Prism software version 4.00 
(GraphPad Software Inc., San Diego, CA). Differences have been considered significant for values 
of p < 0.05. 
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Results and discussion 
 
This section intends to address the lack of existing platforms to obtain coherent information 
pertaining the Ag NPs samples, and to provide more than simple characterization. Ag NPs were 
characterized on tha basis of a separation step (achieved with flow field-flow fractionation) 
followed by characterization through light scattering techniques and fraction collection, to assess 
together the antibacterial activity and the toxic response of human cells to different Ag NPs. The 
nature of the separation, and the simultaneous quantification of free ions, allowed for the 
recollection of separated Ag NPs that could be selectively tested for toxicity and activity. This is a 
new feature that overcomes the a priori calculation of the contributions of ions, medium, and other 
contaminants and provides a direct quantification of particle-specific effect. 
 
In this setting, the approach for the evaluation of Ag NPs was based on a five-step procedure, able 
to accomplish 1. Characterisation of the particles in suspension to match in vitro tests, 2. Testing of 
the nanoparticles to quantify their antibacterial response (acute and in a life-cycle scenario), 3. In-
vitro test to assess toxic response upon contact (skin model), 4. Testing of collected, purified 
nanoparticle to assess particle-specific activity, and 5. Correlation of relevant properties and 
nanoparticles activity (antiseptic/toxic) (Figure 3.1).   
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Fig 3.1. Schematic representation of the multi-step approach used. 1. Characterisation of the 
particles in suspension to match in vitro tests, 2. Testing of the nanoparticles to quantify their 
antibacterial response (acute and in a lyfe-cycle scenario), 3. In-vitro test to assess toxic response 
upon contact (skin model), 4. Testing of collected, purified nanoparticle to assess particle-specific 
activity, and 5. Correlation of relevant properties and nanoparticles activity (antiseptic/toxic and 
particle-specific). 
 
Physicochemical properties (PCP) of nanoparticles: size, shape, surface charge and ionic 
content 
Four different silver nanoparticles have been tested to correlate the particles antiseptic activity and 
toxicity to their physicochemical properties: Ag Pristine, commercial sample provided by 
Colorobbia SpA, and three lab synthesized samples: Ag PVP, Ag CIT, and Ag HEC, respectively 
coated by polyvynilpyrrolidone, citrate and hydroxyethilcellulose added during sol-gel synthesis as 
stabilizers. These preparations were characterized in terms of size, shape, charge and ionic content 
(Table 3.2). 
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Table 3.1. Physicochemical properties of AgNPs. 
Measured 
Parameters 
  
Ag NPs 
Rh (nm) Rg (nm) 
Shape 
factor 
Rg/Rh 
H2O (mV) DMEM (mV) % Ag
+ 
(w/w) 
Pristine  33.0±2.5 18.5±0.15 0.55 -13.0±9.0 -7.61±0.05 3.87±0.08 
Ag PVP 19.0±3.6 13.5±0.39 0.73 -25.0±9.0 -6.99±0.05 3.67±0.09 
Ag CIT 28.0±2.9 13.6±0.25 0.49 -29.0±12.4 -22.00±0.05 0.53±0.03 
Ag HEC 29.0±4.0 25.0±0.4 0.86 +4.4±4.3 +0.06±0.05 0.01±0.02 
 
By using a soft fractionation technique, hollow-fiber flow field-flow fractionation (HF5), coupled 
with multi-angle light scattering (MALS), a hyphenated analytical platform was exploited able to 
in-flow size-separate analytes while calculating the gyration radius (Rg) of the particles, which - 
correlated to the hydrodynamic one (Rh) gives the shape factor. Hollow-fiber flow field-flow 
fractionation (HF5) is a miniaturized and disposable field-flow fractionation device, with the 
advantage of a lower channel volume, flow rates and therefore lower dilution factors. Both narrow 
peaks and low dilution contribute to increased detectability and sensitivity 
103
 
104
. Short analysis 
time and high throughput, ease of use and minimum downtime are determining factors for a 
productive analytical tool; moreover the sample is analyzed in suspension thus not creating artefacts 
through handling (e.g. drying). The advantage of using characterization techniques that can process 
samples in suspension, e.g nano-tracking analysis (NTA) together with FFF, UV-Vis detector and 
multi-angle light scattering (MALS), is that realistic size and shape can be determined whilst the 
orthogonal data provides the information on the particles’ activity49. By using a Diode Array 
Detector (DAD) as a concentration detector we were also able to acquire the absorption spectra of 
the nanoparticles, thus providing a contemporary surface evaluation in terms of different coatings. 
In fact, when acquired during a separation, an absorption spectrum consists of a three-dimensional 
plot, where one dimension is time, one is wavelength and the third is intensity of absorption. Last, 
by coupling Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) to quantify the collected 
free ions, a simultaneous quantification of free Ag+ and nanoparticles characterization and 
collection allowed for a direct calculation of “nano” silver, to understand the amount of nano-
dimensioned metal with respect to the total 
105
. Indeed another advantage of using a miniaturised 
device such as HF5, is that the collected cross-flow resulted to be concentrated enough to allow for 
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low-cost techniques such as GFAAS to be employed, as opposed to ICP-MS. The absorption profile 
measured on-line for each preparation is shown in Figure 3.2, where transmission electron 
microscopy (TEM) images are used as comparison. 
 
Fig 3.2. 3D absorption spectra acquired in flow during HF5 characterization and NPs collection 
and representative TEM images of Ag Pristine (A), Ag PVP (B), AG CIT (C) and Ag HEC (D). 
Scale bar of TEM images represents 40nm. For 3D spectra, horizontal axis represents wavelength 
(nm), depth axis represents time (min), height axis represents absorption intensity (mAU). Ag 
Pristine: min: 330nm, max 450nm. Ag PVP: min 325nm, max 395 nm. Ag CIT: min 327nm, max 
420nm. Ag HEC min 320, max 410 nm. 
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Apart from Ag Pristine, all the particles present a sharp absorption peak in a range between 395 and 
420 nm, confirming a spherical shape. The broadening of Ag Pristine absorption peak towards 
larger wavelengths can represent the influence of a small population of non-spherical particles. 
However, it is more likely that the lack of a stabilising coating (as effective as the other 
preparations) caused a partial –though minimal- aggregation process and the forming aggregates are 
responsible for a red-shift. In fact, we previously observed (chapter 2.1 and 2.2) that PVP-stabilised 
nanoparticles tend to form chain-shaped aggregates when destabilised 
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106
. TEM images (Figure 
3.2) are included as a comparison: whereas HF5-DAD analyses show a mono-modal size 
distribution, TEM images show a variety of species of different size and shape. Indeed, while 
drying silver nanoparticles have chance to rearrange, agglomerate and nucleate into platelets, and 
cannot reflect the original state of the sample. Additionally, big agglomerates are usually omitted in 
TEM analysis. It is also difficult to assess aggregation by TEM due to drying artefacts that can 
result in NP agglomeration during sample preparation 
10
. Hence, all the calculations and the 
predictions have been made basing onto size/shape assessment performed in suspension. 
Hydrodynamic radius measurement, performed with NTA, was determined in MilliQ water to 
match MALS measurements, in order to estimate particles shape
100
. Compared to Dynamic Light 
Scattering (DLS), where the analysis is weighted towards larger particle size, and therefore tends to 
overestimate them
107
, NTA has a lower concentration detection limit, and analyses NPs on a 
particle-by-particle basis. Among the four preparations, Ag PVP particles were the smallest whereas 
the other three were of similar dimensions (Table 3.1). 
After the determination of the different radii, we considered the shape factor. This simple 
comparison of measurable dimensional parameters can in fact provide valuable information about 
the conformation/shape of particles in solution 
34
. 
Observing the reported Rg/Rh ratios (Table 3.1), ranging from 0.49 to 0.86, the particles appear to 
be spherical with a solid core and a less dense coating. In particular, even though the synthesis 
method is the same for Ag Pristine and PVP, both the difference in absorption spectra and Rg/Rh 
forecast a different behaviour between the two. Pristine nanoparticles have a smaller core compared 
to the coating, which is wider than that of Ag PVP particles. This is predictable since the low ratio 
of Ag Pristine sample confirms the presence of less dense coating, confirming that even commercial 
metal nanosols are stabilized by high amount of organic capping agents. Ag PVP, Ag CIT and Ag 
HEC have a spherical and coated shape as well, whereas Ag HEC shows a very compact nature and 
therefore a very thin coating. 
The zeta-potential of the Ag PVP particles was found to be negative in pure water due to the 
interaction of the surface with gluconate residue (generated during synthesis), but it was at least 
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partially neutralized in medium (Table 3.1). Ag Pristine particles undergo the same effect even 
though the decrease is less drastic. Ag CIT particles showed the expected negative charge, whilst 
Ag HEC had a weakly positive potential. The lower absolute values of Zeta potential measured in 
medium, predict a low electrostatic repulsion even though from a visual observation of dispersed 
samples, the steric component of the coating seems to prevent the solid coagulation, segregation and 
sedimentation. In fact, the general mechanism of colloidal stability 
108
 states (according to the 
DLVO theory) that nanoparticles tends to aggregate due to Van der Waals interaction, unless a layer 
of ligands creates a repulsive potential to counteract the attractive force. This repulsion can be of 
steric nature (coating with polymers, such as PVP or uncharged molecules) or of electrostatic 
natures (coating with charged ligands, such as citrate). One direct consequence is that an increase in 
the ionic strength of the solution will shield the electrostatic repulsive potential, and lead to the 
aggregation of the nanoparticles, or their heterocoagulation onto living membranes
109
. 
The ionic content of Ag Pristine and Ag PVP is similar as predictable, since they were obtained 
through the similar synthesis routes. Differences in activity and toxicity then can be dependent on 
the nature of the particles, in particular we expected Ag Pristine to be more active and toxic since 
the hard silver-based core is smaller. Citrate and HEC-coated particles have a considerably lower 
amount of free ions in the solution, due to the more precise stoichiometry applied to the synthesis 
(Table 3.1). Being that the ionic percentage of Ag CIT particles is higher by an order of magnitude 
compared to Ag HEC, a consequent higher activity would have been expected if one considers the 
ionic bioavailability as the only mechanism of action. Nevertheless, the results we obtained showed 
an opposite trend, which makes necessary taking in account surface charge/particle specific activity.  
All the Ag NPs tested, are of a spherical shape; hence this parameter is kept constant. However, 
size, coating, charge and ion release vary for the four preparations and have been evaluated 
individually and as a combination. 
Particle size plays an important role in toxicity and antimicrobial activity; many studies suggest that 
smaller particles have a higher chance to interact with cell membrane and are therefore more 
toxic
110
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111
. A direct prediction and comparison in activity (versus bacteria) and toxicity (versus 
human cell lines) is possible between Ag Pristine and Ag PVP, where size was the main 
distinguishing factor, as reported in Table 3.1. 
Ag Pristine and Ag PVP derived from similar sol-gel synthesis route 
81
 were obtained with different 
reagents concentration and this led to both different dimension and a different absorption spectrum. 
The prediction is that the different Rg/Rh ratio –hence the different coating thickness-, together with 
the bigger size, could lead to a lesser activity of silver Pristine, since a lower ratio is indicative of a 
thicker layer of polymer onto the surface of the particles, making the active surface less available 
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for interactions. Nevertheless, the silver ion content, which has been quantified through flow field-
flow fractionation and atomic absorption, is almost the same between the two preparations. 
In this work, all the physical and chemical characterization of Ag NPs used has been made in 
suspension (water or cell medium), in order to predict the “real” activity of nanoparticles in vitro for 
each preparation and to justify differences in antiseptic/toxic behaviour between similar 
preparations. In fact, the properties of Ag NPs can change during the life cycle of a nanomaterial 
and are partly depending on interactions with the surrounding environment, which may lead to a 
different behaviour of nanomaterials in different situations
112
.  
 
Antimicrobial activity of AgNP over time and under re-contamination  
To quantify the antibacterial effect of the four materials, a range of concentrations from 0.62 to 100 
µg/ml of each preparation has been tested for bactericidal activity at different time points to 
simulate aging of the medical device. Then, it was designed a way to test the ability of Ag NPs to 
display a long lasting antiseptic effect. Lastly, the purified nanoparticles obtained through HF5 were 
tested to identify particle-specific effects. 
An important step is the choice an appropriate model. Escherichia coli is a good model to test 
antibacterial activity of nanoparticles
113
 however it is prudent to measure the activity of 
nanoparticles against  pathogenic strains, since these are more likely encountered in a clinical 
situation. Bacterial strains TOP10 (a K-12 isolate) and CFT073 were chosen for analysis. Strain 
CFT073 is a uropathogenic strain that can form biofilms and cause urinary tract infections 
114
. It 
belongs to sequence type 73 (ST73) of pathogenic E. coli and is one of the most frequent causes of 
E. coli extraintestinal infection. Both strains harboured plasmid pGen-Lux and expressed 
luminescence directly proportional to viability, allowing for monitoring the effect of nanoparticles 
exposure over time through luminescence reads. 
E. coli strain TOP10  was employed for method development prior to the uropathogenic strain. To 
maximise the information obtainable, the luminescence reads were performed until the negative 
control displayed a decrease in intensity when compared to the initial value. In this way, every 
experiment is balanced on the strain tested and the effect of silver nanoparticles can be evaluated 
over the longest period possible, accounting for strain-to-strain variability. E. coli TOP10 was 
incubated with the nanoparticles over a time course of up to 72h, while CFT073 allowed us to carry 
on the experiments up to 96 h without significant loss of luminescence on the untreated control 
(Figure 3.3). 
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Fig 3.3. Viability of bacterial strains E. coli Top10 and CFT073 after 24 hours (red line) and 72 or 
96 hours (green or blue line). Bacteria were cultured at 37°C with shaking at 200 rpm in L Broth to 
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mid-logarithmic phase. 50 µl aliquots of mid-logarithmic cultures (equivalent to ~10
6
 cells) were 
incubated with an equal volume of Ag NPs (from 0.62 to 100 µg/ml final concentration) in 96 well 
plates.  MilliQ H2O was used as a negative control and ethanol as positive control. After 24, 72 and 
96 hours luminescence was read and the RLUs of untreated samples were normalized top 100% 
(see Methods). (A), (C), (E) and (G): E. coli TOP10; (B), (D), (F) and (H): E. coli CFT073. Data 
are means of 3 independent determinations ± SD. Ag Pristine (A, B) Ag PVP (C, D) Ag CIT (E, F) 
and Ag HEC (G, H). 
 
At 24h of exposure (red lines) the E. coli was not viable at concentrations ≥ 40 µg/ml for Ag 
Pristine and Ag PVP (Figure 3.3A-C). On the contrary, Ag CIT and Ag HEC displayed, a smaller 
effect whilst still being dose dependent. Indeed, at the concentration of 100 µg/ml of Ag HEC 
viability dropped to 30% (Figure 3.3G). After 72h of exposure, a similar trend was registered for 
Ag Pristine and Ag PVP, with a decrease of viability to 75 and 65 %, for Ag Pristine and Ag PVP 
respectively, even at the lowest concentration (Figure 3.3A-C). However, Ag HEC induced a clear-
cut killing effect for E. coli, with a complete loss of viability at concentrations ≥ 60 µg/ml. On the 
contrary, Ag CIT was the least effective, with a decrease of viability to 50% for the highest 
concentration used (Figure 3.3E).  
The particles were then tested against the clinical isolate CFT073 and all these agents displayed a 
bactericidal effect. Comparing these results to those obtained with E. coli TOP10 it is observed a 
reduced sensitivity to all the preparations. CFT073 showed a higher resistance to Ag Pristine and 
Ag PVP, and the complete loss of viability was only observed at a concentration ≥ 60 µg/ml (Figure 
3.3B-D) whereas Ag CIT displayed a mediocre effect (Figure 3.3F). None of the three preparations 
showed a time-dependent antimicrobial effect. Instead, Ag HEC showed a time and dose dependent 
toxicity, with a complete loss of viability at doses ≥80 µg/ml, thus maintaining its activity even 
towards a more resilient strain. This observation is in contrast with what could be expected when 
only applying the direct relationship between free ions and toxicant activity, which confirmed the 
presence of particle-specific interaction with living organisms.  
To test the ability of silver nanoparticles to maintain their antiseptic effect, an alternative 
experimental strategy was utilised. The used plates from the previous experiment with CFT073 
were left to dry, the lack of remaining living bacteria was confirmed and another inoculation of 
viable luminescent bacteria was performed (Figure 3.4).  
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Fig 3.4. Viability of bacterial strain CFT073 after 24h (red line) and 96h (blue line) against reused 
Ag NPs. Bacteria, cultured at 37°C with shaking at 200 rpm in L Broth to mid-logarithmic phase. 
50 µl aliquots of mid-logarithmic cultures (equivalent to ~10
6
 cells), were incubated with an equal 
volume of water in the 96 well plates containing the previously employed nanoparticles at different 
concentrations (from 0.62 to 100 µg/ml final concentration). The same well employed for the 
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previous experiment was used as a negative control while ethanol was added instead of water as 
positive control. After 24 and 96 hours luminescence was read and the RLUs of untreated samples 
were normalized top 100% (see Methods). (A), (B), (C) and (D): CFT073. Data are means of 3 
independent determinations ± SD. Ag Pristine (A) Ag PVP (B) Ag CIT (C) and Ag HEC (D). 
 
CFT073 viability was affected in a time dependent manner when bacteria were treated with Ag NPs 
that had previously been used to test killing. The overall antiseptic effect was lower in comparison 
to that of freshly prepared nanoparticles, and one of the concurring factors is that particles were not 
uniformly distributed in the wells, since they were only left to dry after the previous experiment. 
After 24h, particles are ineffective (Ag CIT) or only effective for the highest concentrations: this 
lack of acute toxicity (when compared to the previous experiment) finds explanation in the lack of 
starting free Ag
+
. This is also confirmed by the fact that Ag HEC displayed an almost unvaried 
dose-response pattern (Figure 3.3H and 4.3D). All the preparations except for Ag CIT caused a 
time-dependent decrease in bacterial viability, supporting the hypothesis of the particles being 
interacting with bacteria. 
 
Cytotoxicity assessment of Ag NPs with two relevant cell models: A431 and HaCaT cells.  
Toxic threshold, inflammatory response and oxidative stress were measured in in vitro tests to 
assess the potential hazard of a nanomaterial vary with the cell line considered
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117
. Products 
containing nanomaterials are likely to reach the general consumer and cause intended or unintended 
exposure of the skin. Importantly, the range of products that the consumer face with likelihood of 
exposure to nanomaterials via the skin is broader than the intended ones (for example, 
cosmetics).
118
  
To determine the safety of the Ag NP candidates for use as medical device it is necessary to 
individuate the most relevant exposure scenario according to the SCENIHR Guidelines 
33
. Their use 
is meant to be as surface coating, and can be then defined “surface contacting”, it can interact with 
consumers (workers, patients) through contact thus “facing/interacting with skin tissue”, and is not 
meant for topical use hence the scenario is of “limited contact” (= or <24h). 33  
Therefore, the four Ag NPs were tested for cytotoxicity in two relevant models: A431 (human 
epithelium) and HaCaT (human keratinocytes) 
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121
. Investigating the effect of Ag NPs on two 
human skin models is useful since they represent different skin layers. A431 are representative of 
the outer skin layer while keratinocytes, also part of the stratum granulosus of the skin, can 
simulate in vitro the first effects of penetration of the nanoparticles 
118
. 
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Three in vitro viability tests were performed in order to assess the toxic effects of Ag NPs toward 
human skin cells (Figures 3.5-3.6). The biological assays used in this work allowed for the 
evaluation of different cytotoxicity mechanisms by assessing the presence of viable cells (calcein 
assay), the damaging of cell membranes (lactate dehydrogenase (LDH) assay), or the cellular 
metabolism (resazurin assay). Moreover, the cytotoxicity results obtained allowed to calculate the 
IC50 for each preparation of Ag NPs and to compare the values of IC50 obtained between the 
different assays (Table 3.2).  
Table 3.2. IC50 values (µg/ml) of A431 and HaCaT cells exposed for 24h to Ag NPs 
IC50 values A431 HaCaT 
 Calcein Resazurin Calcein Resazurin 
Ag Pristine 21.87 9.33 10.00 7.58 
Ag PVP 18.62 8.31 12.02 10.96 
Ag CIT >100 >100 >100 >100 
Ag HEC 45.7 21.87 28.84 29.51 
 
A431 and HaCaT cells were exposed to the four preparations of Silver nanoparticles and after 24h 
the cell viability was assessed (Figure 3.5 and 3.6, respectively). 
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Figure 3.5. Cytotoxicity of Ag NPs towards A431 cells. Cells, grown for 24 hours in complete 
growth medium, were treated with different concentrations of Ag NPs or with ethanol (80%), used 
as positive control. After 24h of exposure cell viability was assessed using calcein assay, or 
resazurin assay, or LDH assay (see Methods). (A), (D), (G) and (J): Calcein assay; (B), (E), (H) 
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and (K): resazurin assay; (C), (F), (I) and (L): LDH assay. Data are means of 3 independent 
determinations ± SD. Ag Pristine (A-B-C), Ag PVP (D-E-F), Ag CIT (G-H-I) and Ag HEC (J-K-L). 
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Figure 3.6. Cytotoxicity of Ag NPs towards HaCaT cells. Cells, grown for 24 hours in complete 
growth medium, were treated with different concentrations of Ag NPs or with ethanol (80%), used 
as positive control. After 24h of exposure cell viability was assessed using calcein assay, or 
resazurin assay, or LDH assay (see Methods). (A), (D), (G) and (J): Calcein assay; (B), (E), (H) 
and (K): resazurin assay; (C), (F), (I) and (L): LDH assay. Data are means of 3 independent 
determinations ± SD. Ag Pristine (A-B-C), Ag PVP (D-E-F), Ag CIT (G-H-I) and Ag HEC (J-K-L). 
 
A431 and HaCaT cells reacted similarly to a 24 h exposure to Ag Pristine. Indeed this preparation 
induced an evident decrease in cell viability with calcein assay (Figure 3.5A and 3.6A), whereas 
resazurin assay showed a dose-dependent decrease in viability (Figure 3.5B and 3.6B). Moreover, 
LDH assay showed, for both cell lines, a cytotoxic effect starting from 20 µg/ml, with an increase in 
LDH activity of 60-70% for the highest dose used (100 µg/ml) (Figure 3.5C and 3.6C). 
Ag PVP induced a similar cytotoxic effect onto A431 and HaCaT cells when compared to Ag 
Pristine.  Both calcein and resazurin assay showed a dose-dependent decrease in cell viability 
(Figures 3.5D-E and 3.6D-E). LDH assay confirmed the obtained results (Figures 3.5F and 3.6F).  
On the contrary, Ag CIT, in both cell lines, did not show any cytotoxic effect. This results was 
confirmed by all the three tests used (Figure 3.5G-H-I and 3.6G-H-I), indeed, the values of IC50 
were > 100 µg/ml both for calcein and resazurin assays. 
Lastly, Ag HEC showed a moderate dose-dependent toxicity in both cell lines (Figures 3.5J-K-L 
and 3.6J-K-L). However, no complete loss of viability was observed even at the highest 
concentrations used. 
To better understand the cytotoxic effect of Ag NPs on our skin models, the production of pro-
inflammatory cytokines TNF-α, IL-6, IL-8 and IL-1β was quantified in the culture medium of A431 
and HaCaT cells after 24h of incubation to non-cytotoxic concentrations (2.5 or 5 µg/ml) of 
Pristine, Ag PVP, Ag CIT and Ag HEC (Figure 3.7).  
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Figure 3.7. Secretion of pro-inflammatory cytokines in A431 and HaCaT cells. Cells, grown for 24 
hours in complete growth medium, were treated with 2.5 or 5 µg/ml of Ag NPs or with LPS 
(100ng/ml), as positive control. After 24 hours of treatment, the selected cytokines were measured 
in the extracellular medium (see Materials and Methods). (A), (C), (E) and (G): A431; (B), (D), (F) 
and (H): HaCaT. Data are means of 3 independent determinations ± SD. * p<0.05, **p<0.01 and 
*** p<0.001 vs. untreated, control cells; ## p<0.01 vs. 2.5 µg/ml Ag Pristine; $ p<0.05 and $$$ 
p<0.001 vs 5 µg/ml Ag PVP; §§ p<0.01 vs. 2.5 µg/ml Ag CIT. TNF-α (A-B), IL-6 (C-D), IL-8 (E-F) 
and IL-1β (G-H).  
 
For A431 cells, a significant secretion of TNF-α, IL-6 and IL-8 was registered only after the 
treatment of cells with Pristine and Ag PVP (Figure 3.7A-C-E). In HaCaT cells, a statistically 
significant increase of medium TNF-α, IL-6 and IL-8 was detected after exposure to Pristine, Ag 
PVP and Ag CIT, whereas Ag HEC did not induce any increase of the three cytokines in the culture 
medium (Figure 3.7B-D-F). However, for all the four preparations of Ag NPs, and for both cell 
lines, the production of IL-1β in cell culture medium was not significantly induced compared to the 
control cells (Figure 3.7G-H). The lack of acute inflammatory response for Ag HEC can be a 
promising feature for surface treating applications. Even though skin contact is a possible pathway 
for contamination, a long-term effect for human health is avoided.  
To investigate the effect of long-lasting toxicity of Ag NPs, A431 and HaCaT cells were exposed 
for 24h to the four preparations of Silver nanoparticles. Then, the cells were rinsed and allowed to 
recover in a complete growth medium for additional 6 days (Figure 3.8). 
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Fig 3.8. Recovery A431 and HaCaT cells after exposure to Ag NPs. Cells, grown for 24 hours in 
complete growth medium, were treated with different concentrations of Ag NPs or with ethanol 
(80%), used as positive control. After 24h of exposure cell medium was replaced with full growth 
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medium and cells were cultured for 6 additional days. On the seventh day viability was assessed 
using calcein assay. (A), (C), (E) and (G): A431; (B), (D), (F) and (H): HaCaT. Data are means of 
3 independent determinations ± SD. * p<0.05, **p<0.01 and *** p<0.001 vs. untreated, control 
cells. Ag Pristine (A-B), Ag PVP (C-D), Ag CIT (E-F) and Ag HEC (G-H). 
 
After the recovery period of six days, an increase in viability (assessed with calcein assay) of both 
cell lines treated with Ag NPs was observed, especially for Ag Pristine, Ag PVP and Ag HEC at the 
higher concentrations used (60-80-100 µg/ml), as shown in Figure 3.8. Moreover, the recovery 
experiment confirmed the lower cytotoxicity of Ag CIT (Figure 3.8E-F). In summary, the cellular 
toxicity followed the same pattern observed for bacterial strains, with a higher toxicity for Ag 
Pristine and Ag PVP, and a lower and moderate toxicity for Ag CIT and Ag HEC respectively. 
 
Specific toxicity and antimicrobial activity of FFF fractionated Ag NPs 
In order to assess the toxic and antiseptic effects ascribable to nanoparticles themselves, isolated 
from the suspension of each Ag NP samples and from the starting concentration of Ag
+
, both 
bacteria and cell lines were treated with the FFF fractionated nanoparticles. The concentrations used 
for the specific exposure are calculated, keeping in consideration the dilution factor occurred during 
fractionation and the measured initial Ag
+
 amount. These are 5, 10, 20 µg/ml for Ag Pristine, 5, 10, 
15 µg/ml for Ag PVP and 4, 6, 8 µg/ml for Ag HEC. On these viability of bacterial strain CFT073 
after 24 and 96 hours and cytotoxicity has been measured for the three relevant AgNPs and results 
are shown in Figure 9. Of note, citrate-coated particles have not been screened in this further study 
since their antimicrobial effect was found to be negligible (as shown in Figure 3.3 and 3.4).  
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Fig 3.9. Viability of bacterial strain CFT073 after 24 and 96 hours (A-C-E) and skin cells (B-D-F) 
after 24h when treated with fractionated AgNPs. (A-C-E): Bacteria were cultured at 37°C with 
shaking at 200 rpm in L Broth to mid-logarithmic phase. 50 µl aliquots of mid-logarithmic cultures 
(equivalent to ~10
6
 cells) were incubated with an equal volume of Ag NPs (5, 10, 20 µg/ml for Ag 
Pristine, 5, 10, 15 µg/ml for Ag PVP and 4, 6, 8 µg/ml  for Ag HEC) in 96 well plates.  MilliQ H20 
was used as a negative control and ethanol as positive control. After 24 and 96 hours luminescence 
was read and the RLUs of untreated samples were normalised top 100% (see Methods). (A), (C), 
(E): CFT073. Data are means of 3 independent determinations ± SD. * p<0.05, **p<0.01 and *** 
p<0.001 vs. untreated, control bacterial cells.  # p<0.05 and ## p<0.01  vs 5 µg/ml Ag Pristine; ; $ 
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p<0.05 vs 10 µg/ml Ag Pristine;: ## p<0.01 vs. 5 µg/ml Ag PVP; : # p<0.05 and ### p<0.001 vs 4 
µg/ml Ag HEC; vs. 4 µg/ml. (B-D-F): Cells, A431 and HaCaT, grown in complete growth medium 
for 24h , were treated with different concentrations of Ag NPs (5, 10, 20 µg/ml for Ag Pristine, 5, 
10, 15 µg/ml for Ag PVP and 4, 6, 8 µg/ml  for Ag HEC) or with ethanol (80%), used as positive 
control. After 24h of exposure cell viability was assessed using calcein assay. Data are means of 3 
independent determinations ± SD. * p<0.05, **p<0.01 and *** p<0.001 vs. untreated, control 
bacterial cells. # p<0.05 and ### p<0.001  vs 5 µg/ml Ag Pristine;  $ p<0.05 and $$ p<0.01 vs 10 
µg/ml Ag Pristine; ## p<0.01 vs. 5 µg/ml Ag PVP;; $ p<0.05  vs 10 µg/ml Ag PVP. Ag Pristine (A, 
B), Ag PVP (C, D) and Ag HEC (E, F). 
 
Interestingly, pristine and PVP-coated nanoparticles exerted a similar effect on the pathogenic strain 
CFT073, at both time points. The antimicrobial activity is preserved and increased respect to 
unfractionated samples (e.g. for fractionated Ag PVP we observed a loss of viability of 80% at 15 
µg/ml as opposed to 60% for the unfractionated sample). The acute effect of these two preparations 
could reflect the fact that nanoparticles establish a new equilibrium by releasing ions in the new 
medium, and therefore a certain (and equal) amount of Ag+ is present both for Ag Pristine and Ag 
PVP. Ag HEC nanoparticles did not show a strong antimicrobial effect after 24h, which is linked to 
their initial lesser amount of free Ag+ ions; we however observed a dose-dependent response. 
Nevertheless, after 96h, viability of CFT073 was reduced to 27% even at the very low 
concentrations used (4, 6, 8 µg/ml) (Figure 3.9 E).  
Fractionated Ag Pristine and Ag PVP determined a higher decrease in viability of A431 and HaCaT 
cells than the unfractionated samples (Figure 3.9 B-D). Ag HEC did not produce any significant 
toxic effect in A431 cells, and HaCaT viability remained well over 50% when compared to the 
untreated cells (Figure 3.9 F). 
 
Multiparametric assessment of best Ag NPs candidate 
The ranking and evaluation of the most suitable Ag NPs across the four under investigation to be 
used as antimicrobial agent with reduced acute toxicity was performed by taking into all the 
parameters involved from the PCC to the in vitro and antiseptic response. 
The results reported a highest toxicity (assessed with viability assays and the determination of 
cytokines secretion) towards human skin cells and antiseptic activity on bacteria, respectively, for 
both Ag Pristine and Ag PVP, suggesting that the higher content of Ag+ plays a crucial role in 
determine the toxicity of Silver Ag NPs (Figure 3.3-4-5-6)
122
. However, the effect on the viability 
of CFT073, A431 and HaCaT cells was evaluated also using the fractionated and collected 
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nanoparticles where the only available silver was the solid phase contained in the nanostructure and 
the ionic phase adsorbed on it. The results showed a higher toxic/antiseptic effect compared to that 
of the entire sol (Figure 3.9). This seems to correlate with the hypothesis of a particle size-
dependent activity/toxicity. Indeed, as showed in Figure 3.9 (A-C) fractionated Ag PVP is more 
active/toxic than fractionated Ag Pristine, and this is coherent with the lower size of Ag PVP 
particles. In fact, free silver ions can be sequestrated by the medium and made less available, while 
the particles –being stable- maintain their potential. Moreover, the increase observed for 
fractionated samples of Ag Pristine and Ag PVP can be also partially due to a destabilizing effect 
caused by dilution and subsequent different equilibrium achieved between Ag NPs and free ions, 
compared to the initial preparations. However, when diluted to obtain stock concentration for the 
previous experiments the nanoparticles did not show this deviation from linearity, and the dilution 
effect can be taken out from the concurring parameters to cause destabilization and hence increased 
toxicity. Purification of nanoparticles through FlFFF is also able to remove the impurities without 
affecting the characteristics of the NPs. Those impurities present in Ag NPs suspensions do not only 
include Ag+ but also the residual reducing and stabilizing agents from the synthesis process that 
could hinder or modify the overall activity.  
Ag CIT and Ag HEC were expected to be both less toxic and less antiseptic, since the acute effect 
mediated by ion release is minor. Indeed, they are both less toxic than Ag Pristine and Ag PVP, 
either to bacteria strains or to the cell lines. For Ag HEC the difference between the activity of 
unfractionated and fractionated samples was very low (Figure 3.3G-H, 3.4D, 3.5J-K-L, 3.6J-K-L, 
3.9E-F), and this can be explained with the fact that the free ion concentration in the starting 
material was low enough not to interfere particularly with the particle-specific activity. Moreover, 
this work reported that Ag HEC is more effective in term of activity and toxicity (viability assays) 
than Ag CIT suggesting that other parameters than ionic concentration become relevant in this case. 
By simply following the theory of silver ions being the active element, Ag CIT should have been 
toxic (even though less than Ag Pristine and Ag PVP) and Ag HEC should have had a negligible 
activity, since the difference in ionic content of the two sols is more than one order of magnitude 
(Table 3.1). However, these two preparations have the same size but we reported opposite surface 
charge (Ag CIT is negatively charged and Ag HEC is positively charged). When considering 
surface charge of the nanoparticles, one should also consider the counterpart’s one, and both cells 
and bacteria have a negatively charged membrane. Similarly charged particles tend to repulse each 
other with proportion to the magnitude of the (negative) potential. Therefore, by taking in account 
surface charge then the lowest activity found in Ag CIT finds explanation and suggests that for a 
low ionic content (<1%), the main role is played by attractive forces 
26
 
122
.  
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As found in previous studies 
26
 on differently charged particles, as the absolute value of the negative 
potential decreases, the electrostatic barrier between membranes is reduced and the chance of cell-
particle interaction increases, determining a higher toxicity. Repulsion turns to attraction when cells 
and bacteria are exposed to positively charged particles like Ag HEC.  
Hence, when screening for the best Ag NP candidate, particle activity is a relevant aspect to be 
considered: differently charged materials exert a relevant influence on the overall activity, 
especially when longer exposure is considered. Therefore, particles cannot be disregarded only as 
Ag ions-release devices. When focusing on a real-life scenario, a further step is necessary and it 
involves accounting for the time of action of the candidate compounds. Indeed, if the 24h exposure 
to cells is sufficient to describe skin contact, the antimicrobial potential needs to be monitored over 
a longer amount of time, and a specific experimental design has to be set up for the scope. In fact, 
nanoparticles can have a long-term effect and measuring their activity over a too short span can lead 
to a biased evaluation. This long-term activity is also linked to the fact that bacteria can be selected 
through the previous use of silver ions-based antiseptics, widely used, that can increase resistance 
and cancel the acute toxicity determined by free ions 
123
. On the other hand, nanoparticles need time 
to exert their particle-specific interaction and could have a delayed bacterial toxicity. By re-infusing 
living bacteria on dried plates containing used nanoparticles, the long-lasting antiseptic potential of 
Ag Pristine, Ag PVP, Ag CIT and Ag HEC was confirmed and so was the particle-specific activity: 
the dose-dependent effect is similar to that of newly diluted nanoparticles and ion-dependent effect 
is to be considered negligible (Figure 3.4).  
The applicability of these nanoparticles, or of similar engineered ones, is desirable as they showed 
to be good candidates for surface treatment when the correct time points were considered
124
. In fact 
the lack of individuation of long-term antiseptic effect would have disqualified Ag HEC, which 
instead seems to be the most interesting candidate since we did not report an inflammatory effect on 
human skin cells (Figure 3.8), and, moreover, after the recovery experiment cell viability is above 
50% for all the concentration used (Figure 3.7).  
To summarize the results in a compact view the property-effect relationships between the evaluated 
parameters was rationalized, establishing a basis to categorize the key parameters needed to predict 
nanoparticle activity. Scheme 1 shows how the different physicochemical properties (PCP) of the 
Ag NPs can impact toxicity on skin cells and antiseptic activity. 
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Scheme 3.1. Summary of physicochemical properties of the four Ag NPs preparations and their 
impact on skin toxicity and antiseptic activity. 
 
By exploiting this multi-step approach, based on characterization, toxicity assessment and activity 
evaluation, it is possible to extrapolate which combination of physicochemical properties is more 
effective. This result can be expanded over the four candidates screened and represents a process for 
the selection of the required PCP set needed for a successful antiseptic medical device.  
This selection is visualized in scheme 3.2.  
  
Scheme 3.2. Qualitative representation of positive outcomes and correlated physicochemical 
properties of the four candidates. Colours refer to toxicity towards human skin cells/bacteria. Red: 
high toxicity; orange: low toxicity; yellow: very low toxicity and green: non toxic  
 
As shown in Scheme 3.1 and 3.2, small particles with a negative surface charge and a higher ionic 
content like Ag PVP are acutely toxic and, even though antiseptic, have a small window of 
concentrations that can be exploited for surface treatment since the two trends go accordingly. Even 
bigger particles, as Ag Pristine, that possess the same charge and ion content parameters, display a 
similar behaviour. Strongly negatively charged particles like Ag CIT do not show remarkable 
effects and are not good candidates. Instead, the combination of a positive surface charge, a very 
101 
 
low amount of free silver ions, and a size above 20nm leads to the best candidate, represented in 
this work by Ag HEC.   
In fact, this preparation showed a low acute toxicity, a good cellular recovery after a 24h exposure, 
and a remarkable long-term antiseptic activity. This is especially true for purified particles, where 
the decrease in bacterial viability was 80% (at 96h of exposure) even for very low concentrations of 
nanoparticles.  
 
Conclusions 
In this work, it has been developed and performed a five-step approach to assess and identify the 
purpose specific applicability window of candidate Ag NPs as antimicrobials in healthcare settings 
while also protecting consumer safety upon occasional or unintentional exposure. 
Flow field-flow fractionation, coupled online with UV and MALS detectors, and offline with 
Atomic Absorption, provided together with NTA all the needed information to evaluate each 
nanoparticle descriptor in a realistic medium, allowing for the determination of the key parameters 
for the safe development of antiseptic nanoparticles. Moreover, the separation step provided 
purified particles for individual testing. Efficacy aspects were evaluated by monitoring the long-
term effect of nanoparticles onto luminescent strains of E. coli and of CFT073, a pathogenic strain 
present in hospitals and responsible for Urinary Tract Infections. Safety aspects were addressed by 
studying toxicity, inflammatory response and cellular recovery upon exposure of skin models to Ag 
NPs. Lastly, the design of experiments to verify preservation of antiseptic activity and particle-
specific effects, led to a realistic evaluation of the best candidate materials in correlation with their 
physicochemical requirements.  
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Chapter 4 - Utility of HF5-derived fractions and 
parameters in the evaluation of AgNPs in their final 
state/application 
 
 
This chapter is based on the investigation of the potential of antiseptic silver nanoparticle (Ag NPs) 
preparations as surface coating in healthcare settings. 
In particular, if on one hand the use of Ag NPs can provide a longer lasting effect and a lesser 
resistance from bacteria, the exposure of consumers to a nano-dimensioned substance can lead to 
particle specific effects. 
Moreover, if a coated material is usubject to degradation (e.g. washing/moisture) it is important to 
understand whether there is loss of coating and in which measure (nanoparticles or ions).  
To investigate the “nano” related risk and toxicity mechanism of silver nanoparticles and to extend 
this study to their close-to-market application, a work plan based on the selection of the most 
informative tests was developed. The analytical platform devised was applied both in the 
characterization steps (to provide the properties set propedeuic to candidate selection) and as a 
cross-check tool to verify the final results obtained. 
 
 
Materials and methods 
 
Silver nanoparticles.  
For this study three different silver nanoparticles suspensions (Ag NPs) have been employed. 
Polyvinylpyrrolidone-coated sample (Ag PVP, 0.5 wt% silver concentration), Hydroxyethyl 
cellulose-coated sample (Ag HEC1, 0.5 wt% silver concentration) and a variant of the 
Hydroxyethyl cellulose-coated sample (Ag HEC2, 0.5 wt% silver concentration, modified 
synthesis) were synthesised in ISTEC-CNR (Faenza, Italy). Ag PVP was obtained using glucose as 
a reducing agent and polyvinylpyrrolidone as capping agent. The synthesis reaction occurred in 
basic environmental and at 70°C by microwave heating, which enables homogeneous heating and 
rapid achievement of the desired temperatures. The Ag HEC1 was synthesized, at room 
temperature, reducing a solution of AgNO3 by hydroxyethyl cellulose which was also used as 
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capping agent. The reduction synthesis was catalysed by NaOH (Sigma Aldrich)
81
. Ag HEC2 was 
likewise synthesised as Ag HEC1, but with a lower NaOH/Ag ratio. 
 
HF5-UV-MALS.  
HF5 analyses were performed using the same setup already described.  A volume of Ag NPs of 5µl 
was injected for the characterization of the sample in order to avoid saturation of the scattering 
signal, while a volume of Ag NPs of 100 µl was injected to collect both the ionic fraction and the 
isolated nanoparticles.  
The table below provides the methods specifications. 
Table 4. Flow conditions for HF5 analyses  
Steps   
↓Method  
Focus 
(ml/min) 
Focus-injection 
(ml/min) 
Elution 
(ml/min) 
Elution-injection 
(ml/min) 
Particle 
characterization 
Vc=0.35 
Vx=0.80 
Time=2 min 
Vc=0.35 
Vx=0.80 
Time=3 min 
Vc=0.35 
Vx=0.1 
Time=10 min 
Vc=0.35 
Vx=0 
Time=3 min 
cationic Ag 
collection and 
fraction 
collection  
Vc=0.35 
Vx=0.80 
Time=0.5 min 
Vc=0.35 
Vx=0.8 
Time=20 min 
Vc=0.35 
Vx=0.1 
Time=10 min 
Vc=0.35 
Vx=0 
Time=3 min 
 
Ag+/Ag determination.  
The Ag+/Ag ratio was determined in Milli-Q water, analysing samples through an ad-hoc analytical 
method described in Chapter 2.2, able to retain Ag NPs and filtrate away Ag+ ions. The subsequent 
quantification of ionic Ag with GFAAS was used to estimate the Ag+/Ag ratio. To quantify the 
ionic fraction a volume of 10 ml was collected, 1 ml of conc. HNO3 was added and the 
concentration of Ag was determined with atomic absorption spectroscopy by interpolation on a 
standard calibration curve (LoD = 0.2ppb) following opportune dilution. Pd and Mn(NO3)2 were 
used as modifiers to prevent analyte loss. Each quantitative analysis was repeated three times and 
the ionic silver amount, expressed as percentage on the total silver content, is listed in Table 4.1. By 
subtraction, the amount of “nano” silver present in the collected nanoparticles was obtained and by 
correlating it with the fraction volume the subsequent concentration was determined. 
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Nanoparticle Tracking Analysis (NTA). The average hydrodynamic radius of silver nanoparticles 
in water was characterized using Nanoparticle Tracking Analysis (NTA) developed by Malvern 
Instruments Limited (Wiltshire, UK). This technique utilizes the properties of light scattering and 
Brownian motion to obtain particle size distributions of samples in liquid suspension. A NS500 
instrument, equipped with a 405 nm laser in conjunction with software version NTA 3.1, was used 
for the purpose of this study. Silver nanoparticles at the concentration of 200µg/ml in Milli-Q water 
were vortexed for 5 s to disperse the particles and then diluted at 0.2 µg/ml. The four different 
dispersions were then analyzed via NTA for the measurement of hydrodynamic diameter at room 
temperature. All measurements were carried out three times in MilliQ water to match the Rg 
determination. Results are reported as average mode ± standard deviation. 
 
Zeta potential.  
Zeta potential of Ag NPs (200µg/ml), diluted 10 fold in Milli-Q water and Dulbecco's Modified 
Eagle Medium (DMEM), were evaluated using a Zetasizer Nano Z (ZEN5600, Malvern 
Instruments, UK). Three zeta potential measurements were taken for each sample, each made of 20 
accumulations. Measurements were carried out at 25 °C, and elaborated using Smoluchowski 
model. 
 
Scanning Transmission Electron Microscopy (STEM).  
The observations of particle size distribution and morphology were made using a FESEM (Gemini 
Column, Zeiss), equipped with the annular STEM Detector. One drop of diluted nanoparticle 
suspension in deionized water (20 μg/mL) was deposited on a film-coated copper grid and then 
dried at air. Image analysis was performed on more than 180 particles for each system to calculate 
the particle size distribution shown as a histogram, average diameter and standard deviation. 
 
Incubation with the Ag NPs.  
Silver nanoparticles dispersed in a stock solution at a concentration of 5000 µg/ml in Milli-Q water 
were diluted in medium to reach the desired range of concentrations (2.5-80µg/ml).  
 
Preparation of Ag-coated supports.  
A plasma pre-treatment on glass supports was performed, before the deposition, in order to active 
the surface favouring the Ag NPs adhesion. Ag films were deposited at room conditions onto pre-
treated glass supports by dip coating, as follows: dipping for 30 s in the colloidal suspension (at 0.5 
and 0.05 wt% concentration), withdrawal from the solution at constant velocity (2 mm/s). The 
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coated samples were air dried for 30 min and subsequently treated in oven for 10 min at 130 °C to 
promote adhesion to the support. 
 
Deposited materials testing. 
To test the material release from a real-life scenario, the coated supports were treated with a known 
volume of water for 24h. On each glass slide an idibi® silicon support was deposited: these 
disposable wells guaranteed the creation of a sealed well where water could be inoculated. After 
24h water was removed and pooled for each preparation/concentration, and used to treat cells 1:1 
with water with the same procedure described in the following two paragraphs. 
 
Cell Culture and experimental treatments.  
The viability tests after exposure to Ag NPs preparations were performed onto A431 (human 
epidermoid carcinoma) and HaCaT (human keratinocytes) cell lines representative of human skin 
models. A431 cells were obtained from ATCC (LGC Standard, UK) and cultured in Dulbecco’s 
modified Eagle’s medium (DMEM High Glucose) supplemented with 10% FBS, 2mM L-
glutamine, streptomycin (100 μg/ml) and penicillin (100 U/ml). HaCaT cells, obtained from ATCC 
(LGC Standard, UK), are cultured in Dulbecco’s modified Eagle’s medium (DMEM Low Glucose) 
supplemented with 10% FBS, 2mM L-glutamine, streptomycin (0.01 µg/ml) and penicillin (0.01 
U/ml). Cells were routinely cultured in a humidified atmosphere of 5% CO2 in air in T75 cell 
culture flasks (Nunc, Fisher Scientific, Dublin, Ireland) For cytotoxicity experiments and ELISA 
assay, cells were seeded in complete growth medium on Nunc-96-well multiwell plates, at a density 
of 10×10
3
cells/well and 20×10
3
cells/well, for A431 and HaCaT, respectively. For the recovery 
experiments cells were seeded in complete growth medium on Nunc-96-well multiwell plates, at a 
density of 2×10
3
cells/well and 4×10
3
cells/well, for A431 and HaCaT, respectively. After 24 h, the 
growth medium of the cells was replaced with Ag NPs prepared as previously described. FBS was 
not employed for this stage to avoid the formation of artefact through protein corona effects. Doses 
of NPs were adjusted so as to obtain a silver concentration range from 4 µg/cm
2
 to 160 µg/cm
2
 
(corresponding to a range from 2.5 µg/ml to 100 µg/ml).  
For the particle specific activity, the doses used were adjusted to obtain a final silver concentration 
of 2.5, 5, 10, 20 µg/ml for all the preparations, corresponding to 1.56, 3.12, 6.24, 12.48 µg/cm
2
. 
Since the fractionation led to dilution of the preparation, lower concentrations of total silver were 
used to assess toxicity. After 24h exposure cell viability was assessed using resazurin assay. In all 
the experiments, vehicle (1:1, Milli-Q water: DMEM) was added as negative control. 
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Resazurin assay.  
Resazurin is a substrate that changes colour in response to metabolic activity. It is a non-fluorescent 
molecule converted by intracellular enzymes in the fluorescent compound resorufin (λem = 590 
nm). After 24h of incubation in the presence of Ag NPs, cell viability was tested replacing medium 
with a solution of resazurin (44 mΜ) in serum-free medium. After 1 hour of incubation, 
fluorescence was measured at 604 nm with Epoch microplate reader. No fluorescence signal was 
detected above the background when silver nanoparticles were read alone to verify the absence of 
interference. 
 
High content screening.  
Measurements were carried out using the IN-Cell 1000 automated fluorescent micro- scope system 
(GE Healthcare, USA) and its associated analysis software (In Cell Analyzer System, GE 
Healthcare, USA). 96-wells plates prepared as described above were read on IN-Cell Analyzer 1000 
using two detection channels with two different excitation filters. These included a λ < 503 nm 
filter, which detected the blue fluorescence at 461 nm and a λ > 599 nm filter, which detected the 
red fluorescence at 599 nm. Ten random microscopic fields were sequentially acquired by the IN-
Cell 1000 automated fluorescent microscope system at a magnification of 10×, after carrying out 
image calibration and maintaining constant the acquisition time, contrast, and brightness throughout 
the experiment. Acquired images for each exposure time and dose were then analyzed by the IN-
Cell Analyzer software, which automatically identifies objects based on a fluorescent stain 
following calibration on the control samples. To obtain the cell viability data, an algorithm-based 
software analysis was applied to detect and count the stained nuclei (blue channel) per field. From 
the microscopic fields, the fluorescent staining intensities reflecting lysosomal mass/pH changes 
(red channel) were also quantified for each individual cell present in the fields, by means of the 
analysis software.  
 
Reagents.  
FBS and culture media were purchased from Sigma Aldrich (Dublin, Ireland). ThermoFisher 
(Dublin, Ireland) was the source of all the other chemicals, whenever not specified otherwise. 
 
Statistics.  
Statistic evaluation of effects has been performed with One-way ANOVA with Bonferroni test. 
Statistics have been performed using GraphPad Prism software version 6.0 (GraphPad Software 
Inc., San Diego, CA). Differences have been considered significant for values of p < 0.05.  
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Results and discussion 
 
This chapter focused on the design of the most effective and rapid approach to test the efficacy of 
deposited materials to be used as biorepellent coatings in health facilities. 
The characterization step, necessary to assess the PCP set of optimized Ag NPs, is performed 
wthrough HF5-UV-MALS and NTA. The combined information can predict the activity and 
toxicity of these material according to the selection tool devised in the previous chapter. Step by 
step, the search for the most informative cellular model, activity test, reference sample and endpoint 
can be realized in a funnel-like mode as depicted in Figure 4.1. 
 
 
 
Fig 4.1. Priority-based experimental plan 
 
The nanoparticles used in this study were also used to coat (via plasma treatment followed by dip-
coating) glass cover slides to obtain a model for the application of these antiseptic materials; the 
experimental route followed provided the selection of an optimized method to understand whether 
these materials can be considered stable or tend to release nanoparticles, hence presenting a 
potential source of nano-hazard. In this way, the most “precious” (i.e. difficult to obtain or collect) 
material can be used in a smaller quantity and be tested selectively alond the fastes/most 
informative route. 
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Physicochemical characterization 
Three preparations of silver nanoparticles differing for synthesis route, and capping agents have 
been characterized in terms of size, shape, charge and ionic content; moreover, they have been 
fractionated through HF5-DAD-MALS and the purified NPs were collected. 
After this process, the samples available for study were: 
- Ag PVP, (Polyvinylpyrrolidon coated), negatively charged, and its fractionated batch Ag 
PVPfr 
- Ag HEC1, (hydroxyethilcellulose coated), positively charged, and its fractionated batch Ag 
HEC1fr 
- Ag HEC2, (modified synthesis), positively charged and with a higher amount of free ions, 
and its fractionated batch Ag HEC2fr 
The measured parameters are summarized in Table 4.1. 
Measured 
Parameter
s 
  
 
Rnom (nm) 
TEM 
Rh (nm) 
DLS 
Rh (nm) 
NTA 
Rg (nm) 
MALS 
Shape 
factor 
Rg/Rh 
ζH2O 
(mV) 
ζDMEM 
(mV) 
% Ag
+ 
 (w/w) 
Ag PVP 9 ±2 22.8 ±0.7 16 ±3 13 ±2 0.81 
-17.77 
±0.4 
-2.43 
±0.3 
0.8 ±0.2 
Ag HEC1 13 ±4 91.9 ±0.4 46 ±3 37 ±3 0.80 
+10.14  
± 0.3 
+3.60  
± 0.4 
0.9 ±0.1 
Ag HEC2 9 ±2 
533.67 
±4.3 
22 ±2 62 ±2 (2.81) 
+22.13  
± 0.7 
+5.6  
± 0.04 
1.6 ±0.1 
Table 4.1. PCP set of the three preparations. TEM, DLS and MALS measurements are performed in 
MilliQ water. 
 
The DLS measurements are notably different from the ones performed with other techniques: DLS 
in fact considers the kinetic unit and cannot discern for nanoparticles and aggregates/agglomerated 
with unreacted capping agent. This is particularly evident for Ag HEC2, where the modified 
synthesis led to a higher amount of unreacted hydroxyethylcellulose and Ag+, allowing for the 
preparation of smaller particles with a higher content in free ions. 
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The same sample presents the same issue for the MALS calculation: the determined aspect ratio of 
2.8 would correspond to a rod shaped aggregate/species but all the visual (TEM, NTA) analyses 
confirm that the particles are spherical. Thus, the abundance of free capping agent is shielding the 
particles and forming clusters. 
 
Prediction of activity 
Based on the measured properties (and using NTA-obtained radius for size), a prediction of toxicity 
can be schematized as follows (Figure 4.2): 
 
 
Figure 4.2. Toxicity prediction of the three preparations  
 
In fact, the critical parameters and their impact on cytotoxicity, as defined in the previous chapter, 
are size (smaller particles are more toxic), charge (positively charged particles can get closer 
to/interact with negatively charged biological membranes), and free ions (ions are responsible for 
acute toxicity). 
 
 
Viability assessment 
 
Two cell lines (A431 and HaCaT), accounting for in vitro models of human skin, have been 
employed to test for the toxicity of the three preparations, that have been also compared to AgNO3, 
used as a source of Ag
+ as opposed to “nano” Ag. 
The viability tests performed through resazurin assay showed (and confirmed) that Ag PVP is non-
toxic and Ag HEC1 is only toxic at the highest concentration and for one cell line (HaCaT). 
Interestingly, the IC50 calculated for AgNO3 is of the same order of magnitude of the preparations, 
and closer to Ag HEC2 (Figure 4.2). 
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Fig 4.3. Toxicity evaluation of the three preparations vs AgNO3. Cells, grown for 24 hours in 
complete growth medium, were treated with different concentrations of Ag NPs, AgNO3 or with 
ethanol (80%), used as positive control. After 24h of exposure cell viability was assessed using 
resazurin assay. 
 
The fractionated particles tested individually confirmed this correspondence between properties and 
toxicant effects. In fact, removing from the concurring parameters the amount of free ions, size and 
surface charge are left and still support the prediction of Ag HEC2 being the most toxic preparation 
(Figure 4.4). 
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Fig 4.4. Toxicity evaluation of the three fractionated samples. Cells, grown for 24 hours in 
complete growth medium, were treated with different concentrations of fractionated Ag NPs or with 
ethanol (80%), used as positive control. After 24h of exposure cell viability was assessed using 
resazurin assay. 
 
From the overall results, it was highlighted that the predictions made matched with the experimental 
results, that Silver nanoparticles exert a dose-dependent toxic effect on both cell lines and 
interestingly HaCaT cells are more sensitive to exposure and much more sensitive to Ag+ ions. 
 
Investigation of nanoparticles mechanism of toxicity 
 
High-content screening (HCS) or high-content analysis (HCA) describes a set of analytical methods 
using automated microscopy, multi-parameter image processing, and visualization tools to extract 
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quantitative data from cell populations. HCS typically employs fluorescence imaging of samples in 
a high-throughput format and reports quantitatively on parameters such as spatial distribution of 
targets and individual cell and organelle morphology. In particular, this investigation focused on the 
mitochondrial and the lysosomal activity of A431 and HaCaT cells treated wth nanoparticles (or 
AgNO3) at sub-toxic concentrations. 
 
Mitochondria are responsible for production of ATP and their impairment leads to cell death; they 
release apoptogenic factors through the outer membrane and dissipate the electrochemical gradient 
of the inner membrane, which is thought to occur via formation of the mitochondria permeability 
transition. Mitochondria can proliferate during stimulation of apoptosis leading to an increase in 
total mitochondrial mass. The fluorescent stain accumulates in healthy mitochondria, caused by its 
transmembrane potential, and is absent from depolarized mitochondria that result from a cytotoxic 
compound such as valinomycin (used as positive control). 
Healthy cells have intracellular organelles with characteristic properties, such as lysosomes and 
endosomes that maintain specific internal acidic pH ranges for cells to function normally. 
Nanoparticles can interfere with cell function by affecting the pH of these organelles or by causing 
a change in the number of lysosomes. The Lysosomal stain used in the assay to determine changes 
to lysosomal physiology is a weak base that accumulates in acidic organelles such as lysosomes and 
endosomes. A decrease in the pH of these and other acidic organelles or increase in lysosome 
number or mass caused by compound toxicity directly correlates with the amount of accumulated 
dye in these organelles and, thus, fluorescence intensity. Conversely, an increase in pH or decrease 
in lysosome number or mass results in a decrease in staining intensity. 
Mitochondrial and lysosomal activity of the two cell lines at different time points are shown in 
Figure 4.5 and 4.6. 
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Fig 4.5. Mitochondrial activity of HaCaT and A431 cells exposed to Ag NPs  
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Figure 4.6. Lysosomal activity of HaCaT and A431 cells exposed to Ag NPs  
 
The initial tests were conducted at 24h. At this time points, while HaCaT cells displayed a decrease 
of mitochondrial activity and an uneven increase of lysosomal activity, A431 cells showed no 
variation of mitochondrial activity and a sharp increase of lysosomal activity. 
These differences can be explained considering a different timeframe of action for the two cell 
lines. A431 (human epidermoid carcinoma) are cancer cells and are more resistant, while HaCaT 
(human keratinocytes) had already shown a higher toxic effect after 24h of exposure.  
By individuating an earlier time point (12h) and a later one (48h) for HaCaT and A431, 
respectively, a similar behavior for both cell lines is highlighted. 
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In fact, after an initial stage where the mitochondrial activity is unvaried, and the lysosomal activity 
is increased, both A431 and HaCaT then display a decrease of both parameters measured. 
This could be explained with an initial intake of nanoparticles by cells, causing an increase in 
lysosomal activity; then, particles are dissolved by the acidic pH of the lysosomes and affect the 
whole cell and the mitochondria, lately causing a decrease in lysosomal and mitochondrial activity. 
A similar series of events cannot be caused by ions, which don’t follow the internalization route, as 
verified by the lack of changes in activity for cells treated with AgNO3 (Figure 4.7). 
 
 
Fig 4.7. Mitochondrial (left) and lysosomal (right) activity of HaCaT cells after 12 and 24h 
exposure to Ag NO3 
To continue this study, HaCaT cell lines were prioritized; in fact they showed the same trend as 
A431, but in a shorter time span, and displayed a higher sensitivity towards nanoparticles. 
 
Investigation of toxicant mechanism exerted by fractionated Ag NPs onto HaCaT cells 
 
If one side there are may studies involving the toxic effect of Ag NPs exposure, on the other there 
are no studies focused on the particle-specific activity of these materials. In fact, without a 
technique able to sort and purify particles, it is not possible to test this aspect individually.  
Moreover, since as seen in the previous section the methabolic effect of nanoparticles intake is time 
dependent (and cell line dependent with this regard), studies performed on different cell lines or at 
different times suggested different mechanisms of particle intake and brought different results. 
For example, it has been reported that “lysosomal impairments including alkalization and decrease 
of lysosomal membrane stability were observed in AgNP-treated THP-1 cells."
125
, but also that 
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“Enhanced lysosomal activity was induced at non-cytotoxic concentrations” for human liver-
derived hepatoma (HepG2) cells
126
. As for the mechanisms of nanoparticles intake many 
observations have been made, such as "AgNPs colocalized with lysosomes and their agglomeration 
increased in a dose-dependent manner (50–200 μg Ag/ml). In addition, the fluorescence signals of 
LysoTracker were reduced following exposure to AgNPs, suggesting the elevation of lysosomal 
pH." 
127
, “Probably, the particles were taken up into lysosomes and slightly aggregated therein.” 
128
, and “The autophagy induced by Ag NPs was characterized by enhanced autophagosome 
formation, normal cargo degradation, and no disruption of lysosomal function.” 129. 
The chance of using fractionated nanoparticles as treatment, and the timepoint evaluation for each 
cell line performed in this work, instead, can provide explanation for the different (and sometimes 
opposite) results obtained in various studies, and offer a better choice for evaluating particle 
contribution to toxicity. 
The mitochondrial and lysosomal activity of HaCaT cells exposed for 12 or 24h to fractionated 
nanoparticles are showed in figure 4.8. 
 
Fig 4.8. Mitochondrial (left) and lysosomal (right) activity of HaCaT cells after 12 and 24h 
exposure to fractionated Ag NPs. 
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Fractionated nanoparticles caused a similar decrease of mitochondrial activity when compared to 
the original nanoparticles suspension. However, the variation (increase and subsequent decrease) of 
lysosomal activity is more evident. These materials do not contain the initial fraction of free ions 
and unbound coating; the mechanism observed then is ascribable to the interactions cells have with 
nanoparticles alone. This information is the most relevant in a toxicity evaluation: since the aim of 
this study is (together with the investigation of the toxicant mechanism of Ag NPs) the “quality” 
assessment of close-to-market materials, it is fundamental to verify whether these coated surfaces 
release nanoparticles. 
Lysosomal activity is the most evident of the two modifications, and fractionated nanoparticles 
highlighted this trend.  
Hence, to understand the stability of the deposited materials from a nanorisk point of view, the most 
effective experimental route is to compare the effect of fractionated Ag NPs to the effect of released 
material from the glass surfaces. If the dip coating procedure is successful, and the nanoparticles are 
not dispersed when in contact with humidity, all the candidate Ag NPs can be used and prioritized 
according to their antiseptic potential. Conversely, if one of more preparations are released and lead 
to a source of free nanoparticles, the deposition method needs to be revised, since the toxicity 
evaluations of suspended and materials showed that Ag HEC1 is toxic at high concentrations 
(IC50=72ppm) and Ag HEC2 is toxic even at lower concentrations (IC50= 7.4ppm) for HaCaT cells. 
 
Testing of deposited materials 
 
Each preparation of Ag NPs was used to coat round glass cover slides (13mm diameter) in order to 
test the potential toxicity and stability of these nanoparticles as deposited materials. For each 
preparation, two starting concentrations have been employed (0.5 and 0.05% wt Ag) for the dip 
coating procedure. The deposited materials are shown in Figure 4.9. 
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Figure 4.9. Deposited materials obtained via dip-coating starting from Ag NPs suspensions with a 
concentration of 0.5%(left) and 0.05%(right) wt Ag  
 
To understand the release of the deposited materials, every cover slide was treated with water for 
24h and the supernatant was collected, pooled for every type/concentration of nanomaterial, diluted 
1:10 in water and used to treat HaCaT cells. The experimental setup is schematized in Figure 4.10. 
 
 
Fig 4.10. Experimental procedure to collect released material from coated cover slides 
 
By using silicon inserts, it was possible to set a defined area for the release study; this allows for the 
calculation of a normalised relationship between the amount of material exposed to water and the 
effect induced on HaCaT cells. 
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The lysosomal activity of treated HaCaT cells was then monitored after 12 and 24h as shown in 
Figure 4.11. 
 
Figure 4.11. Lysosomal activity of HaCaT cells after 12(left) and 24(right) hour-exposure to the 
supernatants obtained from the deposited materials. 
 
As shown above, Ag PVP-derived supernatants caused no variation in lysosomal activity both after 
12 and 24h of exposure. Likewise, the coated materials obtained from the lowest concentrations of 
Ag HEC1 and Ag HEC2 showed no effect on HaCaT cells. 
On the contrary, the supernatant obtained from 0.05% suspensions of Ag HEC1 and Ag HEC2 
caused an increase in lysosomal activity after 12h, and a decrease in activity after 24h. 
This experimental setup, then, was successful in individuating that Ag PVP forms a stable 
deposition even when using highly concentrated starting solutions, while Ag HEC1 and Ag HEC2 
can be safely deposited on surfaces starting from a low-concentration suspension, but at high 
concentrations they tend to release nanoparticles that can then interact with cells. 
 
HF5 platform as cross-checking tool 
To confirm these considerations, the pooled supernatants were also analyzed with the same HF5-
DAD-MALS method employed to characterize the nanoparticles (Table 4.1). The peak areas 
@436nm (corresponding to nanoparticles absorption) were compared with the ones obtained with 
the lowest employed concentrations of fractionated Ag NPs used for lysosomal activity evaluation 
onto HaCaT cells. (Table 4.2) 
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Peak area  
Material  
Fractionated Ag 
NPs, 2.5ug/mL 
Supernatant from 
0.05% Ag NPs 
suspension 
Supernatant from 
0.5% Ag NPs 
suspension 
Ag PVP 1.4316 0.303  1.211 
Ag HEC1 123.451 0.415 1991.924 
Ag HEC2 911.156 0.781 1428.256 
Table 4.2. Comparison between peak area of fractionated samples of Ag NPs (lowest concentration 
used for cell treatment) and of supernatant collected from the deposited materials. 
 
As expected, Ag HEC1 and Ag HEC2 supernatants derived from the deposition of the 0.5% 
solutions were the only two samples displaying a higher peak area than the fractionated samples 
used to compare the lysosomal activity (bolded values in Table 4.2), and therefore the only ones 
actually containing a non-negligible amount of released nanoparticles. 
This test can also be a useful candidate for the fast evaluation of the entity of release caused by 
coated material degradation, without involving time-consuming cell cultures, once more data is 
collected. 
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Conclusions 
 
This chapter consisted in the development of a method to quickly screen the potential of antiseptic 
nanoparticles as surface coating agents. 
A work plan based on the selection of the most informative tests was developed: through the 
implementation of a multidisciplinary approach, nanoparticles in suspension have been 
characterized and purified and tested for toxicity, while their toxicant mechanism has been 
investigated through high-content screening.   
The obtained results indicated that HaCaT cells, fractionated Ag nanoparticles, and lysosomal 
activity after 12 and 24h of exposure were the most informative skin model, reference sample, 
toxicant mechanism and time points, respectively.  
The nanoparticles used in this study were also used to coat glass cover slides to simulate their 
application. The aqueous supernatant collected was used to verify the presence of released 
nanoparticles: only Ag PVP showed to form a stable coating even at a high concentration of starting 
material. The results were confirmed via HF5 analysis. 
This approach proved to be effective and can provide a useful tool for the fast screening of nano-
sized coating agents. 
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General conclusions  
 
Silver nanoparticles are a promising tool to control bacterial infections, and their production and 
optimization is an expanding field. However, the controlled production of particles with specific 
paorperties clashes with the lack of suitable tecniques to provide characterization of the newly-
produced materials. This research focusied on the development of a suitable analytical platform able 
to achieve a multiparametric assessment of nanoparticle suspensions, and its integration in the 
development of bioactive nanoproducts in a safety-by-design approach.  
The separation technique used for this task was Hollow-fiber flow field-flow fractionation (HF5) 
coupled with UV, Multi angle light scattering (MALS) and atomic absorption detectors. The 
particles are characterized, separated from the unreacted media and the ionic fraction, collected and 
stored. Different silver nanoparticles have been tested to correlate the particles antiseptic activity 
and toxicity to their physicochemical properties, differing for coating, and ionic content. These 
preparations were characterized in terms of size, shape, charge and free Ag+ amount.  
Safety aspects were addressed by studying toxicity, inflammatory response and cellular recovery 
upon exposure of skin models to Ag NPs. The models of choice were A431 (human epithelium) and 
HaCaT (human keratinocytes), representing different skin layers. Using two novel bioluminescent 
strains of E. coli and CFT073 (a pathogenic strain present in hospitals and responsible for Urinary 
Tract Infections), the real time effects of the AgNPs on bacteria could be evaluated. The results 
obtained show that nanoparticles’ activity depends not only on ionic/nano Ag ratio but also on size 
andsurface charge of the particle. An interesting effect of the positively coatied Ag NPs has been 
observed even though the ionic/nano silver ratio is the lowest amongst all the materials tested. More 
importantly, these particles –though weakly toxic for human skin- remained active for greater than 
7 days and remained micro-biocidal on re-challenge with freshly inoculated bacterial. Areas where 
these materials are in place would have a lower bacterial burden, and these materials could be 
strategically deployed where there might be a higher probability of contamination, e.g. C. difficile 
patient room. 
Due to the thoroughness of thisstudy, it was possible to rationalize the property-effect relationships 
between the evaluated parameters. This estabilished a basis to categorize the key properties needed 
to predict nanoparticle activity and to extrapolate which combination of physicochemical properties 
is the most for a successful antiseptic medical device. 
Taking this result as a starting point, to investigate the “nano” related risk and toxicity mechanism 
of silver nanoparticles and to extend this study to their close-to-market application, a work plan 
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based on the selection of the most informative tests was devised. This part consisted in the 
development of a method to quickly screen the potential of antiseptic nanoparticles as surface 
coating agents. The materials used were Ag NPs optimised on the basis of the previous studies, 
showing the improvements obtained from such an approach. Nanoparticles were characterised, 
purified and tested for toxicity in suspension, and their toxicant mechanism was investigated 
through high-content screening.  
The unfractionated and fractionated particles were both screened for their toxicant mechanism 
(lysosomal and mitochondrial activity) in order to compare global and nano-specific effects. The 
predictive tool previously developed was effective in forecasting the toxicity of Ag NPs with 
different functionalisations. Both HaCaT and A431 cell lines expressed upon exposure an increase 
in lysosomal activity (intake) and a subsequent decrease (particle dissolution) over time, while the 
mitochondrial activity varied in a less evident way. 
The obtained results indicated that HaCaT cells, fractionated Ag nanoparticles, and lysosomal 
activity after 12 and 24h of exposure were the most informative skin model, reference sample, 
toxicant mechanism and time points, respectively.  
Finally, the nanoparticles were used to coat glass cover slides to test for material release upon 
wetting/wear off. The aqueous supernatant collected was used to verify the presence of released 
nanoparticles: only Ag PVP showed to form a stable coating even at a high concentration of starting 
material, while the other materials –though efficiently antiseptic- released Ag NPs to various 
degrees. This approach proved to be effective and able to distinguish amongst candidates, providing 
a useful tool for the fast screening of nano-sized coating agents. 
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